| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | KAT5 SIK1 TACC2 CREBBP PTPRT HNRNPU TTC8 ARID2 CTDP1 MED25 LRP2 SMARCA4 NKX2-5 PAX6 TAF4 BSN USF2 EP300 SMAD4 TBX5 | 7.66e-07 | 753 | 148 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.06e-06 | 104 | 148 | 8 | GO:0016407 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | KAT5 SIK1 TACC2 CREBBP PTPRT TTC8 CTDP1 MED25 LRP2 SMARCA4 NKX2-5 TAF4 USF2 EP300 SMAD4 TBX5 | 6.90e-06 | 582 | 148 | 16 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | TACC2 CREBBP PTPRT TTC8 CTDP1 MED25 LRP2 SMARCA4 NKX2-5 TAF4 EP300 SMAD4 TBX5 | 1.42e-05 | 417 | 148 | 13 | GO:0061629 |
| GeneOntologyMolecularFunction | chromatin binding | KAT5 EP400 YBX1 RBL2 TSPYL1 CREBBP CIC HNRNPU TRIM33 MAPK15 GLI3 SMARCA4 NKX2-5 PAX6 EP300 CUX1 SMAD4 | 3.50e-05 | 739 | 148 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.73e-05 | 51 | 148 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 5.40e-05 | 55 | 148 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide 2-hydroxyisobutyryltransferase activity | 5.46e-05 | 2 | 148 | 2 | GO:0106226 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.46e-05 | 2 | 148 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | peptide crotonyltransferase activity | 5.46e-05 | 2 | 148 | 2 | GO:0140064 | |
| GeneOntologyMolecularFunction | peptide butyryltransferase activity | 5.46e-05 | 2 | 148 | 2 | GO:0140065 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.46e-05 | 2 | 148 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 6.30e-05 | 11 | 148 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 8.22e-05 | 60 | 148 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 8.41e-05 | 140 | 148 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.30e-04 | 66 | 148 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.30e-04 | 66 | 148 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.63e-04 | 3 | 148 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.70e-04 | 15 | 148 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.86e-04 | 78 | 148 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 4.07e-04 | 238 | 148 | 8 | GO:0016747 | |
| GeneOntologyMolecularFunction | SMAD binding | 4.49e-04 | 86 | 148 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 5.38e-04 | 5 | 148 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 5.38e-04 | 5 | 148 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 5.38e-04 | 5 | 148 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 6.34e-04 | 23 | 148 | 3 | GO:0010485 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 6.87e-04 | 54 | 148 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 6.95e-04 | 143 | 148 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acetyltransferase activity | 8.03e-04 | 6 | 148 | 2 | GO:0003985 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 9.15e-04 | 26 | 148 | 3 | GO:0070412 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 9.78e-04 | 102 | 148 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.02e-03 | 27 | 148 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | C-acetyltransferase activity | 1.12e-03 | 7 | 148 | 2 | GO:0016453 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acyltransferase activity | 1.12e-03 | 7 | 148 | 2 | GO:0003988 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 1.30e-03 | 64 | 148 | 4 | GO:0036002 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.38e-03 | 65 | 148 | 4 | GO:0070063 | |
| GeneOntologyMolecularFunction | sphingomyelin phosphodiesterase activity | 1.48e-03 | 8 | 148 | 2 | GO:0004767 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.54e-03 | 31 | 148 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.93e-03 | 303 | 148 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | lncRNA binding | 2.19e-03 | 35 | 148 | 3 | GO:0106222 | |
| GeneOntologyMolecularFunction | Tat protein binding | 2.36e-03 | 10 | 148 | 2 | GO:0030957 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.58e-03 | 37 | 148 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.58e-03 | 37 | 148 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | p53 binding | 2.58e-03 | 77 | 148 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 3.00e-03 | 39 | 148 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EVL CLSTN3 KLHL1 WAS APC DCTN1 PTPRT GSN HNRNPU B4GALT1 BRCA2 ARC SYN1 KIF5B MYO18B EP300 SMAD4 | 3.24e-03 | 1099 | 148 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.38e-03 | 83 | 148 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | alpha-catenin binding | 3.43e-03 | 12 | 148 | 2 | GO:0045294 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 3.43e-03 | 12 | 148 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | cAMP response element binding protein binding | 3.43e-03 | 12 | 148 | 2 | GO:0008140 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 3.43e-03 | 12 | 148 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 3.43e-03 | 12 | 148 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 4.03e-03 | 13 | 148 | 2 | GO:0097677 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 4.51e-03 | 45 | 148 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | ubiquitin-ubiquitin ligase activity | 4.68e-03 | 14 | 148 | 2 | GO:0034450 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 2.95e-06 | 122 | 149 | 8 | GO:0055013 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EVL NES CLSTN3 RIPOR2 KAT5 WAS CTC1 CARMIL3 APC DCTN1 GSN HNRNPU SLC4A2 TBC1D16 TTC8 MAPK15 SYNJ1 ARID2 SMARCA4 KIF5B BBC3 PHIP EP300 INS-IGF2 SMAD4 FBXW7 | 3.64e-06 | 1342 | 149 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | NES RIPOR2 KAT5 CTC1 RBL2 APC SIK1 YTHDC2 TACC2 DCTN1 CREBBP HNRNPU USP8 BRCA2 FBXO31 ARID2 CTDP1 SMARCA4 PAX6 SCRIB PHIP INS-IGF2 | 3.82e-06 | 1014 | 149 | 22 | GO:0000278 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | APC SIK1 HNRNPU ARID2 CTDP1 ALPK3 LRP2 NKX2-5 MYO18B EP300 SMAD4 TBX5 | 4.70e-06 | 327 | 149 | 12 | GO:0048738 |
| GeneOntologyBiologicalProcess | cardiac cell development | 5.31e-06 | 132 | 149 | 8 | GO:0055006 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | RIPOR2 YBX1 SIK1 MYORG HNRNPU CTDP1 ALPK3 NKX2-5 MYO18B EP300 INS-IGF2 SMAD4 TBX5 | 5.46e-06 | 391 | 149 | 13 | GO:0051146 |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 5.73e-06 | 177 | 149 | 9 | GO:0055007 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SP2 KAT5 YBX1 SCAF8 RHOXF2 SIK1 CREBBP CIC HNRNPU SCAF4 TRIM33 RHOXF2B MAPK15 GLI3 MED25 SMARCA4 NKX2-5 PAX6 EP300 INS-IGF2 CUX1 SMAD4 | 6.97e-06 | 1053 | 149 | 22 | GO:0000122 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | APC SIK1 HNRNPU ARID2 CTDP1 ALPK3 LRP2 NKX2-5 MYO18B EP300 SMAD4 TBX5 | 9.09e-06 | 349 | 149 | 12 | GO:0014706 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | NES RIPOR2 KAT5 CTC1 RBL2 APC TACC2 DCTN1 CREBBP HNRNPU USP8 BRCA2 FBXO31 ARID2 CTDP1 SMARCA4 PAX6 PHIP INS-IGF2 | 1.32e-05 | 854 | 149 | 19 | GO:1903047 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 EVL NES CLSTN3 RIPOR2 APC ATP10A SLC1A3 ENAM TTC8 FBXO31 GLI3 LRP2 SMARCA4 ARC KIF5B PAX6 SCRIB TNR PHIP EP300 CUX1 SMAD4 | 1.57e-05 | 1194 | 149 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 1.59e-05 | 44 | 149 | 5 | GO:1905168 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 EVL RIPOR2 APC SLC1A3 TTC8 FBXO31 GLI3 LRP2 ARC KIF5B PAX6 SCRIB TNR EP300 CUX1 SMAD4 | 2.97e-05 | 748 | 149 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | RIPOR2 YBX1 SIK1 MYORG HNRNPU CTDP1 ALPK3 SMARCA4 NKX2-5 MYO18B EP300 INS-IGF2 SMAD4 TBX5 | 3.20e-05 | 531 | 149 | 14 | GO:0042692 |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 3.37e-05 | 221 | 149 | 9 | GO:0035051 | |
| GeneOntologyBiologicalProcess | cell cycle process | NES RIPOR2 KAT5 TDRD9 CTC1 RBL2 APC PUM2 YTHDC2 TACC2 DCTN1 CREBBP HNRNPU USP8 MAPK15 BRCA2 FBXO31 ARID2 CTDP1 SMARCA4 PAX6 PHIP INS-IGF2 ZNF541 FBXW7 | 3.73e-05 | 1441 | 149 | 25 | GO:0022402 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EVL NES CLSTN3 RIPOR2 KAT5 APC PUM2 DCTN1 ATP10A GSN USP8 MAPK15 SYNJ1 FBXO31 MED25 LRP2 KIF5B BBC3 PHIP EP300 INS-IGF2 CUX1 SMAD4 TBX5 | 4.47e-05 | 1366 | 149 | 24 | GO:0051130 |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 4.47e-05 | 177 | 149 | 8 | GO:0030010 | |
| GeneOntologyBiologicalProcess | atrioventricular node cell fate commitment | 5.18e-05 | 2 | 149 | 2 | GO:0060929 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 5.18e-05 | 2 | 149 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 5.18e-05 | 2 | 149 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 5.21e-05 | 291 | 149 | 10 | GO:0032984 | |
| GeneOntologyBiologicalProcess | gland development | VWF ACAT1 CTC1 APC FASN BRCA2 GLI3 SMARCA4 NKX2-5 PAX6 SCRIB USF2 SMAD4 FBXW7 | 5.47e-05 | 558 | 149 | 14 | GO:0048732 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 6.58e-05 | 95 | 149 | 6 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 6.86e-05 | 139 | 149 | 7 | GO:0051983 | |
| GeneOntologyBiologicalProcess | growth | SP2 CLSTN3 CTC1 OGFR APBA1 APC PUM2 ARHGEF11 TTC8 KMT2C BRCA2 GLI3 ARID2 CTDP1 SMARCA4 NKX2-5 TNR BBC3 PHIP EP300 SMAD4 TBX5 | 7.88e-05 | 1235 | 149 | 22 | GO:0040007 |
| GeneOntologyBiologicalProcess | vesicle localization | 7.97e-05 | 247 | 149 | 9 | GO:0051648 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | EVL NES RIPOR2 WAS CARMIL3 APC DCTN1 GSN HNRNPU SLC4A2 TTC8 MAPK15 EP300 SMAD4 | 8.11e-05 | 579 | 149 | 14 | GO:0051493 |
| GeneOntologyBiologicalProcess | chordate embryonic development | TANC2 SP2 CELF4 KAT5 YBX1 APBA1 BRCA2 GLI3 LRP2 SMARCA4 NKX2-5 POLR1B PAX6 SCRIB MYO18B EP300 PRRC2B SMAD4 | 9.74e-05 | 906 | 149 | 18 | GO:0043009 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CABLES2 RIPOR2 KAT5 EP400 CTC1 RBL2 APC PUM2 SIK1 YTHDC2 DCTN1 CREBBP HNRNPU MAPK15 BRCA2 FBXO31 ARID2 SMARCA4 SCRIB PHIP INS-IGF2 FBXW7 | 1.01e-04 | 1256 | 149 | 22 | GO:0051726 |
| GeneOntologyBiologicalProcess | developmental growth | SP2 CLSTN3 CTC1 APBA1 APC PUM2 TTC8 KMT2C BRCA2 GLI3 ARID2 CTDP1 SMARCA4 NKX2-5 TNR EP300 SMAD4 TBX5 | 1.04e-04 | 911 | 149 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | CTC1 RBL2 APC SIK1 YTHDC2 CREBBP HNRNPU BRCA2 FBXO31 ARID2 SMARCA4 SCRIB PHIP INS-IGF2 | 1.06e-04 | 594 | 149 | 14 | GO:0007346 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 1.08e-04 | 257 | 149 | 9 | GO:0007163 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KAT5 EP400 TDRD9 RBL2 PIWIL1 TSPYL1 SRCAP UBN2 CREBBP HNRNPU KMT2C BRCA2 UBR5 ARID2 MED25 SMARCA4 PAX6 TAF4 EP300 | 1.09e-04 | 999 | 149 | 19 | GO:0071824 |
| GeneOntologyBiologicalProcess | muscle cell development | 1.14e-04 | 259 | 149 | 9 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.15e-04 | 35 | 149 | 4 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.15e-04 | 35 | 149 | 4 | GO:0030511 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | RIPOR2 KAT5 CTC1 RBL2 APC PUM2 DCTN1 CREBBP HNRNPU MAPK15 BRCA2 FBXO31 ARID2 SMARCA4 PHIP INS-IGF2 FBXW7 | 1.33e-04 | 845 | 149 | 17 | GO:0010564 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TANC2 SP2 CELF4 KAT5 YBX1 APBA1 BRCA2 GLI3 LRP2 SMARCA4 NKX2-5 POLR1B PAX6 SCRIB MYO18B EP300 PRRC2B SMAD4 | 1.33e-04 | 929 | 149 | 18 | GO:0009792 |
| GeneOntologyBiologicalProcess | epidermis development | COL7A1 RIPOR2 WAS YBX1 APC PUM2 PKP3 SMARCA4 PAX6 SCRIB CUX1 SMAD4 | 1.35e-04 | 461 | 149 | 12 | GO:0008544 |
| GeneOntologyBiologicalProcess | negative regulation of animal organ morphogenesis | 1.55e-04 | 3 | 149 | 2 | GO:0110111 | |
| GeneOntologyBiologicalProcess | cardiac pacemaker cell fate commitment | 1.55e-04 | 3 | 149 | 2 | GO:0060927 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 1.55e-04 | 3 | 149 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 1.55e-04 | 3 | 149 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1.55e-04 | 3 | 149 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | negative regulation of odontogenesis | 1.55e-04 | 3 | 149 | 2 | GO:0042483 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.56e-04 | 111 | 149 | 6 | GO:0033045 | |
| GeneOntologyBiologicalProcess | establishment of T cell polarity | 1.58e-04 | 15 | 149 | 3 | GO:0001768 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | TPSAB1 EVL NES KAT5 SCAF8 APC DCTN1 GSN SCAF4 SYNJ1 ARID2 SMARCA4 KIF5B FBXW7 | 1.58e-04 | 617 | 149 | 14 | GO:0022411 |
| GeneOntologyBiologicalProcess | muscle structure development | RIPOR2 KAT5 YBX1 SIK1 MYORG HNRNPU ARID2 CTDP1 ALPK3 LRP2 SMARCA4 NKX2-5 MYO18B EP300 INS-IGF2 SMAD4 TBX5 | 1.59e-04 | 858 | 149 | 17 | GO:0061061 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | TPSAB1 EVL CLSTN3 RIPOR2 KAT5 TRH APC CREBBP TNFRSF11B SLC4A2 TPSD1 TSC22D1 BRCA2 UBR5 GLI3 CTDP1 TMEM131L PAX6 SCRIB TNR INS-IGF2 SMAD4 FBXW7 TBX5 | 1.68e-04 | 1488 | 149 | 24 | GO:0051241 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | TANC2 KAT5 APC TACC2 DCTN1 HNRNPU MAPK15 BRCA2 SYNJ1 KIF5B PAX6 SCRIB BAIAP3 | 1.71e-04 | 546 | 149 | 13 | GO:0051656 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SP2 KAT5 YBX1 SCAF8 RHOXF2 SIK1 CREBBP CIC HNRNPU SCAF4 TRIM33 RHOXF2B MAPK15 GLI3 MED25 SMARCA4 NKX2-5 PAX6 EP300 INS-IGF2 CUX1 ZNF541 SMAD4 | 1.77e-04 | 1399 | 149 | 23 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor internalization | 1.77e-04 | 39 | 149 | 4 | GO:0099149 | |
| GeneOntologyBiologicalProcess | organelle localization | TANC2 KAT5 APC TACC2 DCTN1 HNRNPU MAPK15 BRCA2 SYNJ1 SYN1 KIF5B PAX6 SCRIB BSN BAIAP3 | 1.79e-04 | 703 | 149 | 15 | GO:0051640 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.89e-04 | 115 | 149 | 6 | GO:1903312 | |
| GeneOntologyBiologicalProcess | establishment of lymphocyte polarity | 1.93e-04 | 16 | 149 | 3 | GO:0001767 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SP2 KAT5 YBX1 SCAF8 RHOXF2 SIK1 CREBBP CIC HNRNPU SCAF4 TRIM33 RHOXF2B MAPK15 GLI3 MED25 SMARCA4 NKX2-5 PAX6 EP300 INS-IGF2 CUX1 ZNF541 SMAD4 | 2.04e-04 | 1413 | 149 | 23 | GO:1902679 |
| GeneOntologyBiologicalProcess | muscle tissue development | APC SIK1 MYORG HNRNPU ARID2 CTDP1 ALPK3 LRP2 NKX2-5 MYO18B EP300 SMAD4 TBX5 | 2.11e-04 | 558 | 149 | 13 | GO:0060537 |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 2.33e-04 | 17 | 149 | 3 | GO:0043923 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 2.39e-04 | 120 | 149 | 6 | GO:0006835 | |
| GeneOntologyBiologicalProcess | behavior | CELF6 CLSTN3 KLHL1 TRH APBA1 DCTN1 SLC1A3 CREBBP CIC SYNJ1 GLI3 ARC PAX6 TNR BAIAP3 EP300 INS-IGF2 | 2.48e-04 | 891 | 149 | 17 | GO:0007610 |
| GeneOntologyBiologicalProcess | embryo development | TANC2 NES SP2 CELF4 RIPOR2 KAT5 YBX1 APBA1 CREBBP BRCA2 GLI3 ARID2 LRP2 SMARCA4 NKX2-5 POLR1B PAX6 SCRIB MYO18B EP300 PRRC2B SMAD4 TBX5 | 2.60e-04 | 1437 | 149 | 23 | GO:0009790 |
| GeneOntologyBiologicalProcess | chromatin organization | KAT5 EP400 TDRD9 RBL2 PIWIL1 TSPYL1 SRCAP UBN2 CREBBP HNRNPU KMT2C BRCA2 UBR5 ARID2 SMARCA4 PAX6 EP300 | 2.65e-04 | 896 | 149 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 2.73e-04 | 123 | 149 | 6 | GO:0051153 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | EVL NES KAT5 APC DCTN1 GSN MAPK15 SYNJ1 KIF5B BBC3 PHIP EP300 INS-IGF2 | 2.78e-04 | 574 | 149 | 13 | GO:0010638 |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 2.86e-04 | 80 | 149 | 5 | GO:0045911 | |
| GeneOntologyBiologicalProcess | atrioventricular node cell development | 3.08e-04 | 4 | 149 | 2 | GO:0060928 | |
| GeneOntologyBiologicalProcess | His-Purkinje system cell differentiation | 3.08e-04 | 4 | 149 | 2 | GO:0060932 | |
| GeneOntologyBiologicalProcess | positive regulation of cardioblast differentiation | 3.08e-04 | 4 | 149 | 2 | GO:0051891 | |
| GeneOntologyBiologicalProcess | positive regulation of intestinal cholesterol absorption | 3.08e-04 | 4 | 149 | 2 | GO:0045797 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 3.08e-04 | 4 | 149 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 3.08e-04 | 4 | 149 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | KAT5 EP400 TDRD9 PIWIL1 TSPYL1 SRCAP CREBBP HNRNPU KMT2C BRCA2 UBR5 ARID2 SMARCA4 PAX6 EP300 | 3.14e-04 | 741 | 149 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 EVL NES CLSTN3 APC TTC8 FBXO31 GLI3 LRP2 ARC KIF5B PAX6 TNR EP300 CUX1 SMAD4 | 3.22e-04 | 826 | 149 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 3.29e-04 | 19 | 149 | 3 | GO:0098712 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 3.39e-04 | 83 | 149 | 5 | GO:0010569 | |
| GeneOntologyBiologicalProcess | regulation of cell development | KAT5 APC TNFRSF11B SLC4A2 TSC22D1 SYNJ1 FBXO31 GLI3 ARID2 LRP2 SMARCA4 TMEM131L PAX6 TNR EP300 INS-IGF2 CUX1 SMAD4 FBXW7 | 3.51e-04 | 1095 | 149 | 19 | GO:0060284 |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 3.59e-04 | 84 | 149 | 5 | GO:0015800 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | CLSTN3 TRH APC CREBBP UBR5 GLI3 LRP2 KIF5B BBC3 BAIAP3 EP300 INS-IGF2 FBXW7 | 3.67e-04 | 591 | 149 | 13 | GO:1903829 |
| GeneOntologyBiologicalProcess | regulation of spindle organization | 3.98e-04 | 48 | 149 | 4 | GO:0090224 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | KAT5 WAS EP400 PUM2 CREBBP BRCA2 ARID2 SMARCA4 TAF4 TNR BBC3 EP300 FBXW7 | 4.10e-04 | 598 | 149 | 13 | GO:0080135 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | KAT5 WAS YBX1 ZNF521 CREBBP HNRNPU PTOV1 KMT2C TSC22D1 GLI3 ARID2 MED25 SMARCA4 NKX2-5 PAX6 TAF4 USF2 MAML3 PHIP EP300 SMAD4 TBX5 | 4.18e-04 | 1390 | 149 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor internalization | 5.02e-04 | 51 | 149 | 4 | GO:0098884 | |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle cell differentiation | 5.02e-04 | 51 | 149 | 4 | GO:0051154 | |
| GeneOntologyBiologicalProcess | postsynaptic endocytosis | 5.02e-04 | 51 | 149 | 4 | GO:0140239 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 5.05e-04 | 138 | 149 | 6 | GO:0055017 | |
| GeneOntologyBiologicalProcess | atrioventricular node cell differentiation | 5.11e-04 | 5 | 149 | 2 | GO:0060922 | |
| GeneOntologyBiologicalProcess | regulation of cardioblast differentiation | 5.11e-04 | 5 | 149 | 2 | GO:0051890 | |
| GeneOntologyBiologicalProcess | positive regulation of intestinal lipid absorption | 5.11e-04 | 5 | 149 | 2 | GO:1904731 | |
| GeneOntologyBiologicalProcess | cardiac septum cell differentiation | 5.11e-04 | 5 | 149 | 2 | GO:0003292 | |
| GeneOntologyBiologicalProcess | regulation of sprouting of injured axon | 5.11e-04 | 5 | 149 | 2 | GO:0048686 | |
| GeneOntologyBiologicalProcess | positive regulation of intestinal absorption | 5.11e-04 | 5 | 149 | 2 | GO:1904480 | |
| GeneOntologyBiologicalProcess | modulation by host of symbiont process | 5.19e-04 | 91 | 149 | 5 | GO:0051851 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 5.19e-04 | 91 | 149 | 5 | GO:0003281 | |
| GeneOntologyBiologicalProcess | DNA damage response | KAT5 WAS EP400 CTC1 APC CREBBP CEP164 MAPK15 BRCA2 UBR5 FBXO31 ARID2 SMARCA4 TAF4 BBC3 EP300 FBXW7 | 5.75e-04 | 959 | 149 | 17 | GO:0006974 |
| GeneOntologyBiologicalProcess | negative regulation of cell population proliferation | ENPP7 RIPOR2 APC IFI35 SLC4A2 B4GALT1 TSC22D1 BRCA2 GLI3 ARID2 MED25 TMEM131L PAX6 SCRIB SMAD4 FBXW7 TBX5 | 5.89e-04 | 961 | 149 | 17 | GO:0008285 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 6.09e-04 | 143 | 149 | 6 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 6.25e-04 | 54 | 149 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 6.32e-04 | 144 | 149 | 6 | GO:0043244 | |
| GeneOntologyCellularComponent | transcription regulator complex | KAT5 RBL2 CREBBP HNRNPU PTOV1 GLI3 ARID2 MED25 NKX2-5 PAX6 TAF4 EP300 ZNF541 SMAD4 TBX5 | 2.07e-05 | 596 | 147 | 15 | GO:0005667 |
| GeneOntologyCellularComponent | Swr1 complex | 9.25e-05 | 13 | 147 | 3 | GO:0000812 | |
| GeneOntologyCellularComponent | postsynapse | TANC2 CLSTN3 CELF4 CARMIL3 APBA1 APC CSMD2 SYAP1 SLC1A3 SLC1A6 PTPRT USP6 USP8 ARC SYN1 KIF5B SCRIB BSN PCDH10 | 9.79e-05 | 1018 | 147 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | Scrib-APC-beta-catenin complex | 1.47e-04 | 3 | 147 | 2 | GO:0034750 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.02e-04 | 287 | 147 | 9 | GO:0035770 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 CLSTN3 CARMIL3 APBA1 APC CSMD2 SLC1A6 PTPRT USP6 USP8 SYNJ1 ARC SCRIB BSN TNR PCDH10 | 2.10e-04 | 817 | 147 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | KAT5 EP400 YBX1 CTC1 SCAF8 U2AF2 NUP42 SRCAP CREBBP HNRNPU KMT2C BRCA2 ARID2 MED25 SMARCA4 NKX2-5 POLR1B PPIL2 NUP188 TAF4 ZNF541 SMAD4 | 2.52e-04 | 1377 | 147 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | kinetochore | 2.99e-04 | 181 | 147 | 7 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome | 3.31e-04 | 307 | 147 | 9 | GO:0000793 | |
| GeneOntologyCellularComponent | dendrite | TANC2 CLSTN3 KLHL1 YBX1 APBA1 APC PUM2 SYAP1 SLC1A3 HNRNPU USP8 LRP2 ARC SYN1 KIF5B BSN | 3.63e-04 | 858 | 147 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 CLSTN3 KLHL1 YBX1 APBA1 APC PUM2 SYAP1 SLC1A3 HNRNPU USP8 LRP2 ARC SYN1 KIF5B BSN | 3.72e-04 | 860 | 147 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 4.40e-04 | 193 | 147 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 5.33e-04 | 94 | 147 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.87e-04 | 96 | 147 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 6.47e-04 | 269 | 147 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | chromatin | SP2 KAT5 EP400 RBL2 RHOXF2 TSPYL1 SRCAP CREBBP CIC TRIM33 RHOXF2B UBR5 ARID2 SMARCA4 NKX2-5 PAX6 TAF4 USF2 EP300 CUX1 SMAD4 TBX5 | 6.74e-04 | 1480 | 147 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 7.23e-04 | 6 | 147 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 8.45e-04 | 104 | 147 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | KAT5 YBX1 APBA1 APC PUM2 YTHDC2 SRCAP SYAP1 SLC1A3 USP20 GSN PTOV1 SYNJ1 UBR5 KIF5B FBXW7 | 9.04e-04 | 934 | 147 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | INO80-type complex | 9.81e-04 | 28 | 147 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.04e-03 | 109 | 147 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.20e-03 | 523 | 147 | 11 | GO:0098984 | |
| GeneOntologyCellularComponent | mast cell granule | 1.34e-03 | 8 | 147 | 2 | GO:0042629 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.36e-03 | 451 | 147 | 10 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.05e-03 | 477 | 147 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.17e-03 | 254 | 147 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | ATPase complex | 2.20e-03 | 129 | 147 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 CLSTN3 KLHL1 YBX1 APBA1 APC PUM2 DCTN1 SYAP1 SLC1A3 HNRNPU USP8 FBXO31 LRP2 ARC SYN1 KIF5B BSN | 2.49e-03 | 1228 | 147 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | synaptic membrane | CLSTN3 APBA1 CSMD2 SYAP1 SLC1A6 PTPRT SYNJ1 ARC SCRIB BSN PCDH10 | 2.81e-03 | 583 | 147 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | chromosomal region | 3.00e-03 | 421 | 147 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.00e-03 | 503 | 147 | 10 | GO:0099572 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.06e-03 | 85 | 147 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | centrosome | CEP85L APC TACC2 DCTN1 CEP164 USP20 HNRNPU TTC8 BRCA2 FBXO31 CTDP1 KIF5B SMAD4 | 3.12e-03 | 770 | 147 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | chromosome, centromeric region | 3.44e-03 | 276 | 147 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | axonal growth cone | 3.90e-03 | 45 | 147 | 3 | GO:0044295 | |
| HumanPheno | Thick eyebrow | U2AF2 CREBBP KMT2C FBXO31 ARID2 SLC35A2 SMARCA4 TAF4 PHIP EP300 SMAD4 | 7.23e-06 | 154 | 71 | 11 | HP:0000574 |
| HumanPheno | Keloids | 2.25e-05 | 13 | 71 | 4 | HP:0010562 | |
| HumanPheno | Hypoplastic aortic arch | 3.12e-05 | 14 | 71 | 4 | HP:0012304 | |
| HumanPheno | Disinhibition | TANC2 KAT5 CEP85L RBL2 TNRC6B SIK1 SRCAP DCTN1 ATP10A SLC1A3 CREBBP CIC SCAF4 KMT2C BRCA2 SYNJ1 GLI3 ARID2 MED25 SMARCA4 SYN1 TAF4 PHIP EP300 SMAD4 | 4.56e-05 | 807 | 71 | 25 | HP:0000734 |
| HumanPheno | Inappropriate behavior | TANC2 KAT5 CEP85L RBL2 TNRC6B SIK1 SRCAP DCTN1 ATP10A SLC1A3 CREBBP CIC SCAF4 KMT2C BRCA2 SYNJ1 GLI3 ARID2 MED25 SMARCA4 SYN1 TAF4 PHIP EP300 SMAD4 | 4.56e-05 | 807 | 71 | 25 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | TANC2 KAT5 CEP85L RBL2 TNRC6B SIK1 SRCAP DCTN1 ATP10A SLC1A3 CREBBP CIC SCAF4 KMT2C BRCA2 SYNJ1 GLI3 ARID2 MED25 SMARCA4 SYN1 TAF4 PHIP EP300 SMAD4 | 4.56e-05 | 807 | 71 | 25 | HP:5200123 |
| HumanPheno | Social disinhibition | TANC2 KAT5 CEP85L RBL2 TNRC6B SIK1 SRCAP DCTN1 ATP10A SLC1A3 CREBBP CIC SCAF4 KMT2C BRCA2 SYNJ1 GLI3 ARID2 MED25 SMARCA4 SYN1 TAF4 PHIP EP300 SMAD4 | 4.56e-05 | 807 | 71 | 25 | HP:5200029 |
| HumanPheno | Abnormally increased volition | TANC2 KAT5 ACAT1 CEP85L RBL2 TNRC6B SIK1 SRCAP DCTN1 ATP10A SLC1A3 CREBBP CIC SCAF4 KMT2C BRCA2 SYNJ1 GLI3 ARID2 MED25 SMARCA4 SYN1 TAF4 PHIP EP300 SMAD4 | 5.50e-05 | 869 | 71 | 26 | HP:5200263 |
| HumanPheno | Abnormal gastrointestinal vascular morphology | 8.73e-05 | 7 | 71 | 3 | HP:0004296 | |
| HumanPheno | Laryngeal cleft | 8.73e-05 | 7 | 71 | 3 | HP:0008751 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.92e-04 | 2 | 71 | 2 | HP:0034227 | |
| HumanPheno | Plantar crease between first and second toes | 1.92e-04 | 2 | 71 | 2 | HP:0008107 | |
| HumanPheno | Y-shaped metatarsals | 1.92e-04 | 2 | 71 | 2 | HP:0010567 | |
| HumanPheno | High axial triradius | 1.92e-04 | 2 | 71 | 2 | HP:0001042 | |
| HumanPheno | Pilomatrixoma | 2.05e-04 | 9 | 71 | 3 | HP:0030434 | |
| MousePheno | abnormal embryo size | CABLES2 NES SP2 ACAT2 YBX1 RBL2 APC UBN2 CREBBP PTOV1 TRIM33 BRCA2 UBR5 GLI3 CTDP1 LRP2 NKX2-5 KIF5B PAX6 SCRIB HS3ST1 PHIP EP300 SMAD4 FBXW7 | 2.08e-06 | 956 | 130 | 25 | MP:0001697 |
| MousePheno | decreased embryo size | CABLES2 NES SP2 YBX1 RBL2 APC CREBBP TRIM33 BRCA2 UBR5 CTDP1 LRP2 NKX2-5 KIF5B PAX6 SCRIB HS3ST1 EP300 SMAD4 FBXW7 | 2.81e-06 | 659 | 130 | 20 | MP:0001698 |
| MousePheno | embryonic lethality during organogenesis | CABLES2 NES SP2 EP400 RBL2 APC CREBBP CEP164 HNRNPU BRCA2 UBR5 GLI3 ARID2 SMARCA4 NKX2-5 KIF5B SCRIB TAF4 MYO18B EP300 FBXW7 TBX5 | 1.77e-05 | 876 | 130 | 22 | MP:0006207 |
| MousePheno | abnormal embryonic growth/weight/body size | CABLES2 NES SP2 ACAT2 YBX1 RBL2 APC UBN2 CREBBP HNRNPU PTOV1 TRIM33 USP8 BRCA2 UBR5 GLI3 CTDP1 LRP2 ARC NKX2-5 KIF5B PAX6 SCRIB HS3ST1 PHIP EP300 SMAD4 FBXW7 | 1.77e-05 | 1295 | 130 | 28 | MP:0002088 |
| MousePheno | perimembraneous ventricular septal defect | 2.33e-05 | 92 | 130 | 7 | MP:0010418 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | CABLES2 SP2 EP400 RBL2 APC CREBBP CEP164 HNRNPU BRCA2 UBR5 ARID2 SMARCA4 NKX2-5 KIF5B TAF4 MYO18B EP300 FBXW7 TBX5 | 2.47e-05 | 700 | 130 | 19 | MP:0011098 |
| MousePheno | abnormal interventricular septum membranous part morphology | 2.50e-05 | 93 | 130 | 7 | MP:0008823 | |
| MousePheno | abnormal prenatal body size | CABLES2 NES SP2 ACAT2 YBX1 RBL2 APC UBN2 CREBBP PTOV1 TRIM33 BRCA2 UBR5 GLI3 CTDP1 LRP2 NKX2-5 KIF5B PAX6 SCRIB HS3ST1 PHIP EP300 SMAD4 FBXW7 | 3.05e-05 | 1116 | 130 | 25 | MP:0010866 |
| MousePheno | abnormal embryo development | CABLES2 SP2 EP400 YBX1 RBL2 APC U2AF2 DIDO1 SRCAP DCTN1 CREBBP CEP164 HNRNPU TRIM33 USP8 HMCN1 BRCA2 UBR5 GLI3 CTDP1 ARC NKX2-5 KIF5B SCRIB EP300 SMAD4 FBXW7 TBX5 | 4.92e-05 | 1370 | 130 | 28 | MP:0001672 |
| MousePheno | postnatal lethality | SP2 COL7A1 CELF4 APC CREBBP CIC TNFRSF11B SLC4A2 B4GALT1 TTC8 BRCA2 SYNJ1 GLI3 SMARCA4 NKX2-5 PAX6 USF2 HS3ST1 PCDH10 PHIP EP300 INS-IGF2 CUX1 TBX5 | 5.45e-05 | 1084 | 130 | 24 | MP:0002082 |
| MousePheno | increased intestinal adenoma incidence | 7.76e-05 | 25 | 130 | 4 | MP:0002404 | |
| MousePheno | abnormal left posterior bundle morphology | 8.58e-05 | 2 | 130 | 2 | MP:0010566 | |
| MousePheno | abnormal prenatal growth/weight/body size | CABLES2 NES SP2 CELF4 ACAT2 YBX1 RBL2 APC UBN2 CREBBP HNRNPU PTOV1 TRIM33 USP8 BRCA2 UBR5 GLI3 CTDP1 LRP2 ARC NKX2-5 KIF5B PAX6 SCRIB HS3ST1 PHIP EP300 SMAD4 FBXW7 | 8.79e-05 | 1493 | 130 | 29 | MP:0004196 |
| MousePheno | postnatal lethality, incomplete penetrance | CELF4 APC CREBBP CIC TNFRSF11B SLC4A2 B4GALT1 TTC8 BRCA2 SMARCA4 NKX2-5 PAX6 USF2 PHIP EP300 CUX1 TBX5 | 1.53e-04 | 669 | 130 | 17 | MP:0011086 |
| MousePheno | abnormal nervous system development | NES SP2 EP400 YBX1 RBL2 TMEM63C APC ZNF521 UBN2 DCTN1 CREBBP CEP164 PTPRT PRX BRCA2 UBR5 GLI3 LRP2 SMARCA4 SYN1 PAX6 SCRIB PHIP EP300 FBXW7 | 2.07e-04 | 1257 | 130 | 25 | MP:0003861 |
| MousePheno | abnormal seizure response to electrical stimulation | 2.10e-04 | 32 | 130 | 4 | MP:0001650 | |
| MousePheno | abnormal heart ventricle shape | 2.56e-04 | 3 | 130 | 2 | MP:0031530 | |
| MousePheno | abnormal atrioventricular bundle morphology | 2.56e-04 | 3 | 130 | 2 | MP:0004117 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | SP2 CELF4 YBX1 APC TNRC6B CREBBP CIC TNFRSF11B SLC4A2 B4GALT1 TTC8 BRCA2 SYNJ1 LRP2 SMARCA4 NKX2-5 PAX6 SCRIB USF2 PHIP EP300 CUX1 TBX5 | 2.57e-04 | 1124 | 130 | 23 | MP:0011112 |
| MousePheno | abnormal embryonic-extraembryonic boundary morphology | 2.67e-04 | 34 | 130 | 4 | MP:0003890 | |
| MousePheno | exencephaly | 2.97e-04 | 230 | 130 | 9 | MP:0000914 | |
| MousePheno | abnormal developmental patterning | SP2 RBL2 APC DCTN1 CEP164 HNRNPU TRIM33 USP8 BRCA2 UBR5 ARC KIF5B SCRIB EP300 SMAD4 | 3.01e-04 | 577 | 130 | 15 | MP:0002084 |
| MousePheno | increased stomach tumor incidence | 3.30e-04 | 15 | 130 | 3 | MP:0010301 | |
| MousePheno | abnormal interventricular septum morphology | EVL CREBBP ARID2 ALPK3 LRP2 SMARCA4 NKX2-5 EP300 INS-IGF2 PRRC2B TBX5 | 3.48e-04 | 342 | 130 | 11 | MP:0000281 |
| MousePheno | embryonic growth arrest | CABLES2 EP400 RBL2 DIDO1 DCTN1 CREBBP HMCN1 ARC EP300 SMAD4 TBX5 | 3.84e-04 | 346 | 130 | 11 | MP:0001730 |
| MousePheno | abnormal myocardium compact layer morphology | 3.92e-04 | 67 | 130 | 5 | MP:0004056 | |
| MousePheno | abnormal cardiovascular development | CELF4 RBL2 APC CREBBP CEP164 B4GALT1 USP8 UBR5 GLI3 ARID2 LRP2 SMARCA4 NKX2-5 MYO18B EP300 PRRC2B FBXW7 TBX5 | 4.43e-04 | 802 | 130 | 18 | MP:0002925 |
| MousePheno | absent olfactory bulb | 4.86e-04 | 17 | 130 | 3 | MP:0003451 | |
| MousePheno | abnormal mammary duct terminal end bud morphology | 5.09e-04 | 4 | 130 | 2 | MP:0013782 | |
| Domain | HSA | 2.02e-06 | 4 | 150 | 3 | SM00573 | |
| Domain | HSA | 2.02e-06 | 4 | 150 | 3 | PS51204 | |
| Domain | HSA_dom | 2.02e-06 | 4 | 150 | 3 | IPR014012 | |
| Domain | HSA | 2.02e-06 | 4 | 150 | 3 | PF07529 | |
| Domain | BROMODOMAIN_1 | 1.11e-05 | 37 | 150 | 5 | PS00633 | |
| Domain | Bromodomain | 1.27e-05 | 38 | 150 | 5 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.86e-05 | 41 | 150 | 5 | PS50014 | |
| Domain | Bromodomain | 2.09e-05 | 42 | 150 | 5 | IPR001487 | |
| Domain | BROMO | 2.09e-05 | 42 | 150 | 5 | SM00297 | |
| Domain | - | 2.09e-05 | 42 | 150 | 5 | 1.20.920.10 | |
| Domain | Bromodomain_CS | 5.21e-05 | 26 | 150 | 4 | IPR018359 | |
| Domain | - | 5.85e-05 | 10 | 150 | 3 | 3.40.47.10 | |
| Domain | Thiolase-like | 5.85e-05 | 10 | 150 | 3 | IPR016039 | |
| Domain | Nuc_rcpt_coact_CREBbp | 6.41e-05 | 2 | 150 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 6.41e-05 | 2 | 150 | 2 | SM00551 | |
| Domain | - | 6.41e-05 | 2 | 150 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 6.41e-05 | 2 | 150 | 2 | IPR010303 | |
| Domain | - | 6.41e-05 | 2 | 150 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 6.41e-05 | 2 | 150 | 2 | PF09030 | |
| Domain | zf-TAZ | 6.41e-05 | 2 | 150 | 2 | PF02135 | |
| Domain | ZF_TAZ | 6.41e-05 | 2 | 150 | 2 | PS50134 | |
| Domain | KAT11 | 6.41e-05 | 2 | 150 | 2 | SM01250 | |
| Domain | Znf_TAZ | 6.41e-05 | 2 | 150 | 2 | IPR000197 | |
| Domain | KIX | 6.41e-05 | 2 | 150 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 6.41e-05 | 2 | 150 | 2 | PF08214 | |
| Domain | Mediator_Med25 | 6.41e-05 | 2 | 150 | 2 | IPR021394 | |
| Domain | KIX | 6.41e-05 | 2 | 150 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 6.41e-05 | 2 | 150 | 2 | IPR031162 | |
| Domain | DUF902 | 6.41e-05 | 2 | 150 | 2 | PF06001 | |
| Domain | Med25 | 6.41e-05 | 2 | 150 | 2 | PF11232 | |
| Domain | - | 6.41e-05 | 2 | 150 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 6.41e-05 | 2 | 150 | 2 | IPR013178 | |
| Domain | KIX_dom | 6.41e-05 | 2 | 150 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 6.41e-05 | 2 | 150 | 2 | PS51727 | |
| Domain | TIL_dom | 1.73e-04 | 14 | 150 | 3 | IPR002919 | |
| Domain | Thiolase_AS | 6.31e-04 | 5 | 150 | 2 | IPR020610 | |
| Domain | Thiolase_C | 9.41e-04 | 6 | 150 | 2 | PF02803 | |
| Domain | Nuc_rcpt_coact | 9.41e-04 | 6 | 150 | 2 | IPR009110 | |
| Domain | THIOLASE_2 | 9.41e-04 | 6 | 150 | 2 | PS00737 | |
| Domain | THIOLASE_1 | 9.41e-04 | 6 | 150 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 9.41e-04 | 6 | 150 | 2 | PS00099 | |
| Domain | Thiolase_N | 9.41e-04 | 6 | 150 | 2 | IPR020616 | |
| Domain | Thiolase_C | 9.41e-04 | 6 | 150 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 9.41e-04 | 6 | 150 | 2 | IPR020613 | |
| Domain | Thiolase | 9.41e-04 | 6 | 150 | 2 | IPR002155 | |
| Domain | Thiolase_N | 9.41e-04 | 6 | 150 | 2 | PF00108 | |
| Domain | RNA_pol_II-bd | 1.31e-03 | 7 | 150 | 2 | IPR006903 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 1.31e-03 | 7 | 150 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 1.31e-03 | 7 | 150 | 2 | PS00714 | |
| Domain | CTD_bind | 1.31e-03 | 7 | 150 | 2 | PF04818 | |
| Domain | SDF | 1.31e-03 | 7 | 150 | 2 | PF00375 | |
| Domain | - | 1.31e-03 | 7 | 150 | 2 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 1.31e-03 | 7 | 150 | 2 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 1.31e-03 | 7 | 150 | 2 | IPR018107 | |
| Domain | Helicase_C | 1.72e-03 | 107 | 150 | 5 | PF00271 | |
| Domain | HELICc | 1.72e-03 | 107 | 150 | 5 | SM00490 | |
| Domain | RPR | 1.74e-03 | 8 | 150 | 2 | SM00582 | |
| Domain | CID_dom | 1.74e-03 | 8 | 150 | 2 | IPR006569 | |
| Domain | CID | 1.74e-03 | 8 | 150 | 2 | PS51391 | |
| Domain | Helicase_C | 1.79e-03 | 108 | 150 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.87e-03 | 109 | 150 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.87e-03 | 109 | 150 | 5 | PS51192 | |
| Domain | DEXDc | 1.87e-03 | 109 | 150 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.95e-03 | 110 | 150 | 5 | IPR014001 | |
| Domain | SNF2_N | 2.12e-03 | 32 | 150 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.12e-03 | 32 | 150 | 3 | PF00176 | |
| Domain | RRM | 2.61e-03 | 230 | 150 | 7 | PS50102 | |
| Domain | Trypsin_dom | 2.95e-03 | 121 | 150 | 5 | IPR001254 | |
| Domain | Trypsin | 2.95e-03 | 121 | 150 | 5 | PF00089 | |
| Domain | Peptidase_S1_PA | 3.16e-03 | 123 | 150 | 5 | IPR009003 | |
| Domain | WH1 | 3.36e-03 | 11 | 150 | 2 | SM00461 | |
| Domain | WH1/EVH1_dom | 3.36e-03 | 11 | 150 | 2 | IPR000697 | |
| Domain | WH1 | 3.36e-03 | 11 | 150 | 2 | PF00568 | |
| Domain | - | 3.61e-03 | 244 | 150 | 7 | 3.30.70.330 | |
| Domain | C8 | 4.01e-03 | 12 | 150 | 2 | PF08742 | |
| Domain | TIL | 4.01e-03 | 12 | 150 | 2 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 4.72e-03 | 13 | 150 | 2 | IPR014853 | |
| Domain | C8 | 4.72e-03 | 13 | 150 | 2 | SM00832 | |
| Domain | WH1 | 4.72e-03 | 13 | 150 | 2 | PS50229 | |
| Domain | Nucleotide-bd_a/b_plait | 4.89e-03 | 258 | 150 | 7 | IPR012677 | |
| Domain | PDZ | 5.64e-03 | 141 | 150 | 5 | PF00595 | |
| Domain | TRYPSIN_SER | 5.99e-03 | 90 | 150 | 4 | IPR033116 | |
| Domain | PDZ | 6.90e-03 | 148 | 150 | 5 | SM00228 | |
| Domain | VWF_type-D | 7.14e-03 | 16 | 150 | 2 | IPR001846 | |
| Domain | VWFD | 7.14e-03 | 16 | 150 | 2 | PS51233 | |
| Domain | VWD | 7.14e-03 | 16 | 150 | 2 | SM00216 | |
| Domain | VWD | 7.14e-03 | 16 | 150 | 2 | PF00094 | |
| Domain | - | 7.29e-03 | 150 | 150 | 5 | 2.30.42.10 | |
| Domain | PDZ | 7.49e-03 | 151 | 150 | 5 | PS50106 | |
| Domain | PDZ | 7.70e-03 | 152 | 150 | 5 | IPR001478 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 4.02e-06 | 15 | 107 | 4 | MM1439 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 5.32e-06 | 16 | 107 | 4 | M8516 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 6.92e-06 | 17 | 107 | 4 | MM1509 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 9.54e-06 | 65 | 107 | 6 | M39682 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.11e-05 | 19 | 107 | 4 | M18933 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.70e-05 | 21 | 107 | 4 | M39593 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | KAT5 EP400 RBL2 APC CREBBP HNRNPU TRIM33 SMARCA4 EP300 INS-IGF2 SMAD4 | 1.76e-05 | 301 | 107 | 11 | MM15983 |
| Pathway | REACTOME_CARDIOGENESIS | 4.81e-05 | 27 | 107 | 4 | M48011 | |
| Pathway | REACTOME_GASTRULATION | 5.57e-05 | 129 | 107 | 7 | M46433 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 1.02e-04 | 142 | 107 | 7 | M39575 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.42e-04 | 66 | 107 | 5 | M27938 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.46e-04 | 14 | 107 | 3 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.22e-04 | 16 | 107 | 3 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 2.22e-04 | 16 | 107 | 3 | M27940 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.81e-04 | 42 | 107 | 4 | M17541 | |
| Pathway | PID_P73PATHWAY | 3.31e-04 | 79 | 107 | 5 | M19 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.41e-04 | 20 | 107 | 3 | M27881 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.72e-04 | 48 | 107 | 4 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.11e-04 | 49 | 107 | 4 | M618 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.62e-04 | 5 | 107 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 5.62e-04 | 5 | 107 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 5.62e-04 | 5 | 107 | 2 | M48023 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION | 5.62e-04 | 5 | 107 | 2 | M49011 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 5.62e-04 | 5 | 107 | 2 | M27228 | |
| Pathway | WP_DISORDERS_IN_KETOLYSIS | 5.62e-04 | 5 | 107 | 2 | M48310 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.89e-04 | 22 | 107 | 3 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 5.89e-04 | 22 | 107 | 3 | MM1443 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 5.96e-04 | 51 | 107 | 4 | M665 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 5.96e-04 | 51 | 107 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 5.96e-04 | 51 | 107 | 4 | MM14499 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 6.74e-04 | 23 | 107 | 3 | MM1527 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 6.74e-04 | 23 | 107 | 3 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.66e-04 | 24 | 107 | 3 | M13404 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 7.66e-04 | 24 | 107 | 3 | M16517 | |
| Pathway | WP_MALE_INFERTILITY | 8.23e-04 | 145 | 107 | 6 | M39856 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 8.39e-04 | 6 | 107 | 2 | M22062 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION | 8.39e-04 | 6 | 107 | 2 | M47665 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.66e-04 | 25 | 107 | 3 | M27880 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 9.08e-04 | 330 | 107 | 9 | M7847 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 9.71e-04 | 58 | 107 | 4 | M29616 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 9.73e-04 | 26 | 107 | 3 | M27053 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 9.73e-04 | 26 | 107 | 3 | MM14793 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.17e-03 | 7 | 107 | 2 | MM1573 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.21e-03 | 28 | 107 | 3 | M48253 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.21e-03 | 28 | 107 | 3 | MM14711 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.49e-03 | 110 | 107 | 5 | M48259 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.55e-03 | 8 | 107 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.55e-03 | 8 | 107 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.55e-03 | 8 | 107 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.55e-03 | 8 | 107 | 2 | M46443 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | KAT5 YBX1 RBL2 ZNF521 TNRC6B U2AF2 CREBBP TRIM33 KMT2C GLI3 ARID2 CTDP1 MED25 SMARCA4 NKX2-5 TAF4 BBC3 MAML3 EP300 SMAD4 TBX5 | 1.55e-03 | 1387 | 107 | 21 | M734 |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 1.64e-03 | 31 | 107 | 3 | M27805 | |
| Pathway | WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM | 1.68e-03 | 113 | 107 | 5 | M48336 | |
| Pubmed | EP400 TNRC6B DIDO1 SRCAP UBN2 DCTN1 SYAP1 CREBBP SCAF4 KMT2C FASN SYNJ1 ARID2 SMARCA4 KIF5B SCRIB TAF4 EP300 CUX1 PRRC2B | 4.05e-13 | 549 | 151 | 20 | 38280479 | |
| Pubmed | SP2 KAT5 EP400 YBX1 SCAF8 ZNF521 TNRC6B PUM2 DIDO1 PPP6R1 SRCAP UBN2 CREBBP CIC SCAF4 TRIM33 KMT2C GLI3 ARID2 LRP2 SMARCA4 NKX2-5 PPIL2 PAX6 TAF4 CCDC86 EP300 CUX1 PRRC2B FBXW7 | 6.34e-13 | 1429 | 151 | 30 | 35140242 | |
| Pubmed | TANC2 NES WDR81 APC TNRC6B DIDO1 PPP6R1 ARHGEF11 UBN2 DCTN1 SLC1A3 GSN HNRNPU SYNJ1 UBR5 SMARCA4 ARC SYN1 KIF5B SCRIB TAF4 BSN TNR CUX1 PRRC2B | 7.21e-13 | 963 | 151 | 25 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 EP400 CTC1 KTI12 PPP6R1 SRCAP ZNF236 ARHGEF11 DCTN1 CIC MYORG TBC1D16 MST1R KMT2C FASN SYNJ1 SH3TC1 ZNF341 SLC35A2 CTDP1 ARC NUP188 EP300 PRRC2B | 8.68e-11 | 1105 | 151 | 24 | 35748872 |
| Pubmed | TANC2 EP400P1 KAT5 EP400 TNRC6B U2AF2 YTHDC2 PPP6R1 TSPYL1 SRCAP CREBBP TRIM33 SH3TC1 UBR5 GLI3 ARID2 LRP2 SMARCA4 NUP188 SCRIB TAF4 PHIP EP300 PRRC2B | 1.06e-10 | 1116 | 151 | 24 | 31753913 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 APC TACC2 PPP6R1 NUP42 SRCAP UBN2 CREBBP CIC TRIM33 BRCA2 SYNJ1 UBR5 ARID2 MED25 PPIL2 BSN PRRC2B | 1.11e-10 | 588 | 151 | 18 | 38580884 |
| Pubmed | CLSTN3 RIPOR2 EP400 SCAF8 TNRC6B PUM2 PPP6R1 KLHL29 USP8 UBR5 ZFR2 SCRIB PCDH10 BAIAP3 PRRC2B | 3.48e-10 | 407 | 151 | 15 | 12693553 | |
| Pubmed | RIPOR2 VWF WAS APC NUP42 ARHGEF11 DCTN1 CREBBP CIC KMT2C TSC22D1 ARID2 KIF5B USF2 EP300 CUX1 | 4.51e-10 | 486 | 151 | 16 | 20936779 | |
| Pubmed | EVL EP400 YBX1 DIDO1 UBN2 CREBBP CIC GSN HNRNPU SCAF4 TRIM33 KMT2C FASN UBR5 ARID2 SMARCA4 PPIL2 KIF5B TAF4 USF2 EP300 CUX1 PRRC2B | 4.92e-10 | 1103 | 151 | 23 | 34189442 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EP400 TNRC6B PUM2 DIDO1 YTHDC2 TACC2 PPP6R1 SRCAP DCTN1 SYAP1 CIC HNRNPU SCAF4 USP8 FASN SYNJ1 ARID2 SMARCA4 KIF5B SCRIB PRRC2B | 7.94e-10 | 934 | 151 | 21 | 33916271 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KAT5 EP400 RBL2 PPP6R1 DCTN1 CREBBP CIC TRIM33 FASN SH3TC1 UBR5 SMARCA4 NKX2-5 KIF5B SCRIB USF2 CCDC86 EP300 CUX1 SMAD4 | 1.10e-09 | 857 | 151 | 20 | 25609649 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | ACAT1 SCAF8 TNRC6B PUM2 NUP42 CREBBP CIC B4GALT1 TRIM33 KMT2C PKP3 NUP188 MAML3 EP300 PRRC2B | 1.69e-09 | 457 | 151 | 15 | 32344865 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES EP400 ACAT1 YBX1 U2AF2 YTHDC2 SRCAP GSN HNRNPU SCAF4 FASN SMPDL3B UBR5 PKP3 SMARCA4 KIF5B NUP188 SCRIB CCDC86 PHIP RAB5C | 4.03e-09 | 1024 | 151 | 21 | 24711643 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CABLES2 EVL EP400P1 SCAF8 TMEM63C TNRC6B U2AF2 ZNF236 UBN2 ATP10A CREBBP HNRNPU B4GALT1 KLHL29 TTC8 KMT2C TSC22D1 SMPDL3B SH3TC1 PKP3 TAF4 BAIAP3 MAML3 EP300 CUX1 | 6.59e-09 | 1489 | 151 | 25 | 28611215 |
| Pubmed | Interaction network of human early embryonic transcription factors. | KAT5 EP400 ZNF521 UBN2 CREBBP TRIM33 KMT2C ARID2 SMARCA4 TAF4 EP300 PRRC2B | 4.94e-08 | 351 | 151 | 12 | 38297188 |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 7.03e-08 | 10 | 151 | 4 | 16751102 | |
| Pubmed | 7.15e-08 | 25 | 151 | 5 | 36708875 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 10347196 | ||
| Pubmed | HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. | 8.02e-08 | 3 | 151 | 3 | 16001085 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 19748655 | ||
| Pubmed | Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. | 8.02e-08 | 3 | 151 | 3 | 9920877 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 9590171 | ||
| Pubmed | SP2 RHOXF2 ZNF521 DIDO1 TACC2 CREBBP CIC KMT2C RHOXF2B GLI3 SMARCA4 PAX6 USF2 MAML3 PHIP CUX1 | 9.02e-08 | 709 | 151 | 16 | 22988430 | |
| Pubmed | 1.10e-07 | 11 | 151 | 4 | 27067865 | ||
| Pubmed | Gli3 is required for maintenance and fate specification of cortical progenitors. | 1.10e-07 | 11 | 151 | 4 | 21525285 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | CLSTN3 YBX1 CEP85L DIDO1 ZNF236 DCTN1 HNRNPU SLC4A2 PTOV1 USP6 PKP3 SLC35A2 CTDP1 SMARCA4 POLR1B USF2 BAIAP3 SMAD4 | 1.24e-07 | 925 | 151 | 18 | 28986522 |
| Pubmed | KAT5 EP400 SCAF8 APC TNRC6B PUM2 DIDO1 YTHDC2 TSPYL1 ARHGEF11 UBN2 CIC CEP164 SCAF4 TRIM33 KMT2C ARID2 MED25 POLR1B TAF4 ZBTB11 CCDC86 RAB5C | 1.41e-07 | 1497 | 151 | 23 | 31527615 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SP2 EP400 RBL2 APC CREBBP TRIM33 KMT2C SYNJ1 ARID2 SMARCA4 EP300 CUX1 | 1.92e-07 | 398 | 151 | 12 | 35016035 |
| Pubmed | YBX1 RBL2 TNRC6B PUM2 U2AF2 TSPYL1 DCTN1 HNRNPU FASN UBR5 FBXO31 PKP3 TAF4 ZBTB11 PRRC2B | 1.93e-07 | 655 | 151 | 15 | 35819319 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EP400 ACAT1 YBX1 U2AF2 DIDO1 UBN2 CIC HNRNPU SCAF4 TRIM33 BRCA2 ARID2 SMARCA4 NKX2-5 TAF4 CCDC86 PHIP CUX1 | 1.95e-07 | 954 | 151 | 18 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 KAT5 EP400 U2AF2 DIDO1 SRCAP UBN2 CIC HNRNPU SCAF4 KMT2C PKP3 SMARCA4 NUP188 PAX6 TAF4 USF2 CCDC86 EP300 CUX1 SMAD4 | 2.14e-07 | 1294 | 151 | 21 | 30804502 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | YBX1 SCAF8 OGFR HDHD5 TNRC6B U2AF2 DIDO1 TACC2 PPP6R1 DCTN1 SLC1A3 GSN HNRNPU USP8 FASN UBR5 PKP3 SMARCA4 PPIL2 KIF5B CCDC86 RAB5C | 2.22e-07 | 1415 | 151 | 22 | 28515276 |
| Pubmed | TANC2 EVL NES VWF ACAT1 APC YTHDC2 ARHGEF11 DCTN1 SLC1A3 GSN HNRNPU FASN SYNJ1 SMARCA4 SYN1 KIF5B SCRIB BSN TNR RAB5C PRRC2B | 2.69e-07 | 1431 | 151 | 22 | 37142655 | |
| Pubmed | RIPOR2 TRH CTC1 APC DIDO1 TACC2 SRCAP DUS3L UBN2 DCTN1 SLC1A3 KMT2C SYNJ1 ZNF341 LRP2 TMEM131L NUP188 USF2 BAIAP3 | 2.69e-07 | 1084 | 151 | 19 | 11544199 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 28398509 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 9194565 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 15653675 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 11581372 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 15548196 | ||
| Pubmed | APC TNRC6B PPP6R1 DCTN1 CIC FASN BRCA2 SYNJ1 UBR5 LRP2 ZBTB11 CUX1 | 3.24e-07 | 418 | 151 | 12 | 34709266 | |
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 3.30e-07 | 14 | 151 | 4 | 17641689 | |
| Pubmed | 3.62e-07 | 152 | 151 | 8 | 38360978 | ||
| Pubmed | 3.63e-07 | 34 | 151 | 5 | 30894540 | ||
| Pubmed | 4.05e-07 | 65 | 151 | 6 | 26655900 | ||
| Pubmed | 5.80e-07 | 69 | 151 | 6 | 32238831 | ||
| Pubmed | 5.97e-07 | 16 | 151 | 4 | 33907211 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP2 EP400 TNRC6B TACC2 UBN2 CREBBP HNRNPU TRIM33 BRCA2 PPIL2 KIF5B TAF4 | 6.12e-07 | 444 | 151 | 12 | 34795231 |
| Pubmed | Fstl1 is involved in the regulation of radial glial scaffold development. | 7.78e-07 | 17 | 151 | 4 | 26382033 | |
| Pubmed | TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. | 7.97e-07 | 5 | 151 | 3 | 9679056 | |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 19448667 | ||
| Pubmed | CLSTN3 VWF CEP85L RBL2 APBA1 APC ZNF521 NUP42 DCTN1 CREBBP TRIM33 USP8 SYNJ1 LRP2 SMARCA4 PAX6 SCRIB ZBTB11 EP300 CUX1 | 8.19e-07 | 1285 | 151 | 20 | 35914814 | |
| Pubmed | TANC2 CSMD2 IFI35 SLC1A3 CREBBP CIC USP6 USP8 ARID2 BSN MAML3 EP300 CUX1 PRRC2B | 8.35e-07 | 638 | 151 | 14 | 31182584 | |
| Pubmed | KAT5 EP400 ACAT2 TNRC6B SRCAP UBN2 CREBBP MED25 PPIL2 KIF5B SCRIB CCDC86 PHIP EP300 | 9.50e-07 | 645 | 151 | 14 | 25281560 | |
| Pubmed | 9.96e-07 | 18 | 151 | 4 | 33323119 | ||
| Pubmed | NES ACAT1 U2AF2 DIDO1 YTHDC2 FASN UBR5 SMARCA4 KIF5B NUP188 ZBTB11 CCDC86 PHIP PRRC2B | 1.10e-06 | 653 | 151 | 14 | 22586326 | |
| Pubmed | KAT5 EP400 SCAF8 DIDO1 DCTN1 CREBBP SLC1A6 TRIM33 USP8 FASN BRCA2 UBR5 SMARCA4 EP300 RAB5C | 1.13e-06 | 754 | 151 | 15 | 35906200 | |
| Pubmed | 1.23e-06 | 242 | 151 | 9 | 34011540 | ||
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 1.26e-06 | 19 | 151 | 4 | 28916710 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SP2 KAT5 RBL2 RHOXF2 APC ZNF236 CREBBP CIC BRCA2 GLI3 NKX2-5 POLR1B PAX6 MAML3 EP300 SMAD4 | 1.50e-06 | 877 | 151 | 16 | 20211142 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL EP400 SCAF8 PUM2 DIDO1 YTHDC2 SYAP1 CIC SCAF4 FASN PKP3 CTDP1 SMARCA4 SCRIB CCDC86 | 1.56e-06 | 774 | 151 | 15 | 15302935 |
| Pubmed | The epigenetic state of EED-Gli3-Gli1 regulatory axis controls embryonic cortical neurogenesis. | 1.57e-06 | 20 | 151 | 4 | 35931079 | |
| Pubmed | Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly. | 1.57e-06 | 20 | 151 | 4 | 32294449 | |
| Pubmed | 1.57e-06 | 20 | 151 | 4 | 34220450 | ||
| Pubmed | 1.57e-06 | 20 | 151 | 4 | 22542597 | ||
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 18485870 | ||
| Pubmed | New developments in the genetics and activation of mast cell proteases. | 1.59e-06 | 6 | 151 | 3 | 12217407 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 23933087 | ||
| Pubmed | Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. | 1.59e-06 | 6 | 151 | 3 | 18509338 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 10887155 | ||
| Pubmed | Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex. | 1.71e-06 | 46 | 151 | 5 | 35864088 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EP400 U2AF2 YTHDC2 CIC HNRNPU SMARCA4 NKX2-5 PAX6 SCRIB TAF4 USF2 CUX1 SMAD4 | 1.76e-06 | 583 | 151 | 13 | 29844126 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CABLES2 EP400 RBL2 WDR81 APC U2AF2 DIDO1 CREBBP MAPK15 NUP188 SCRIB CCDC86 EP300 SMAD4 | 2.27e-06 | 695 | 151 | 14 | 23602568 |
| Pubmed | 2.44e-06 | 263 | 151 | 9 | 34702444 | ||
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 2.77e-06 | 7 | 151 | 3 | 21079652 | |
| Pubmed | Pokemon (FBI-1) interacts with Smad4 to repress TGF-β-induced transcriptional responses. | 2.77e-06 | 7 | 151 | 3 | 25514493 | |
| Pubmed | The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. | 2.77e-06 | 7 | 151 | 3 | 14767476 | |
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 16332960 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 2.77e-06 | 7 | 151 | 3 | 9590696 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DIDO1 SRCAP UBN2 CIC ARID2 SMARCA4 PPIL2 PAX6 TAF4 ZBTB11 CCDC86 PHIP CUX1 | 2.78e-06 | 608 | 151 | 13 | 36089195 |
| Pubmed | MEK Is a Key Regulator of Gliogenesis in the Developing Brain. | 3.39e-06 | 24 | 151 | 4 | 22998872 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | EP400 APC YTHDC2 SRCAP UBR5 ARID2 SMARCA4 POLR1B NUP188 SCRIB ZBTB11 | 3.86e-06 | 440 | 151 | 11 | 34244565 |
| Pubmed | 3.96e-06 | 209 | 151 | 8 | 36779422 | ||
| Pubmed | Centrosome anchoring regulates progenitor properties and cortical formation. | 4.02e-06 | 25 | 151 | 4 | 32238932 | |
| Pubmed | 4.02e-06 | 25 | 151 | 4 | 22479201 | ||
| Pubmed | Gliogenic radial glial cells show heterogeneity in the developing mouse spinal cord. | 4.42e-06 | 8 | 151 | 3 | 16280634 | |
| Pubmed | Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). | 4.42e-06 | 8 | 151 | 3 | 14691252 | |
| Pubmed | ACAT2 RBL2 ZNF236 DCTN1 KMT2C FASN UBR5 GLI3 ARID2 SLC35A2 TMEM131L PPIL2 NUP188 TAF4 USF2 BBC3 EP300 RAB5C FBXW7 | 5.27e-06 | 1327 | 151 | 19 | 32694731 | |
| Pubmed | 5.54e-06 | 27 | 151 | 4 | 36915679 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 5.79e-06 | 102 | 151 | 6 | 15778465 | |
| Pubmed | 5.98e-06 | 157 | 151 | 7 | 30186101 | ||
| Pubmed | 6.17e-06 | 222 | 151 | 8 | 37071664 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 6.45e-06 | 28 | 151 | 4 | 31600191 | |
| Pubmed | 6.48e-06 | 104 | 151 | 6 | 10470851 | ||
| Pubmed | UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. | 6.61e-06 | 9 | 151 | 3 | 23028370 | |
| Pubmed | Endosomal trafficking defects alter neural progenitor proliferation and cause microcephaly. | 6.61e-06 | 9 | 151 | 3 | 35013230 | |
| Pubmed | 6.61e-06 | 9 | 151 | 3 | 28781964 | ||
| Pubmed | 6.61e-06 | 9 | 151 | 3 | 32267917 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES EP400 ACAT1 ACAT2 YBX1 U2AF2 SRCAP DUS3L DCTN1 CREBBP HNRNPU FASN UBR5 SMARCA4 POLR1B KIF5B SCRIB CCDC86 PHIP | 6.94e-06 | 1353 | 151 | 19 | 29467282 |
| Pubmed | 7.45e-06 | 29 | 151 | 4 | 34461288 | ||
| Pubmed | Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. | 7.45e-06 | 29 | 151 | 4 | 15525990 | |
| Interaction | SOX9 interactions | KLHL1 EP400 UBN2 CREBBP CIC KMT2C ARID2 SMARCA4 PAX6 EP300 CUX1 FBXW7 | 7.67e-12 | 97 | 150 | 12 | int:SOX9 |
| Interaction | HNF4A interactions | KAT5 EP400 ZNF521 SRCAP UBN2 CREBBP CIC TRIM33 KMT2C ARID2 SMARCA4 TAF4 EP300 CUX1 SMAD4 | 2.27e-09 | 275 | 150 | 15 | int:HNF4A |
| Interaction | FEV interactions | SP2 EP400 ZNF521 UBN2 CREBBP CIC KMT2C ARID2 TAF4 EP300 CUX1 PRRC2B | 4.03e-08 | 203 | 150 | 12 | int:FEV |
| Interaction | PAX6 interactions | EP400 ZNF521 SRCAP UBN2 CREBBP CIC KMT2C SYNJ1 ARID2 SMARCA4 PAX6 EP300 CUX1 PRRC2B SMAD4 | 1.02e-07 | 366 | 150 | 15 | int:PAX6 |
| Interaction | TLE3 interactions | SCAF8 UBN2 CREBBP CIC SCAF4 BRCA2 UBR5 ARID2 SMARCA4 NKX2-5 PPIL2 PAX6 TAF4 EP300 CUX1 | 1.45e-07 | 376 | 150 | 15 | int:TLE3 |
| Interaction | IRF1 interactions | 1.92e-07 | 83 | 150 | 8 | int:IRF1 | |
| Interaction | YY1 interactions | KAT5 EP400 DIDO1 SRCAP CREBBP CIC CEP164 USP8 FASN ARID2 SMARCA4 PAX6 TAF4 EP300 SMAD4 FBXW7 | 2.92e-07 | 454 | 150 | 16 | int:YY1 |
| Interaction | GATA2 interactions | CREBBP CIC KMT2C FASN ARID2 SMARCA4 EP300 CUX1 PRRC2B SMAD4 FBXW7 | 2.97e-07 | 199 | 150 | 11 | int:GATA2 |
| Interaction | SMARCA4 interactions | EP400 RBL2 SRCAP CREBBP CIC TRIM33 GLI3 ARID2 SMARCA4 NKX2-5 PAX6 PHIP EP300 RAB5C FBXW7 TBX5 | 3.69e-07 | 462 | 150 | 16 | int:SMARCA4 |
| Interaction | SP7 interactions | EP400 SCAF8 CREBBP CIC SCAF4 TRIM33 KMT2C ARID2 SMARCA4 EP300 CUX1 PRRC2B FBXW7 | 4.68e-07 | 304 | 150 | 13 | int:SP7 |
| Interaction | CREBBP interactions | KAT5 WAS RBL2 APC TACC2 SRCAP CREBBP PTOV1 TRIM33 GLI3 MED25 SMARCA4 POLR1B PAX6 BBC3 EP300 CUX1 SMAD4 | 5.30e-07 | 599 | 150 | 18 | int:CREBBP |
| Interaction | WWTR1 interactions | EP400 TNRC6B DIDO1 SRCAP DCTN1 SYAP1 CREBBP SYNJ1 ARID2 SMARCA4 KIF5B SCRIB EP300 CUX1 PRRC2B | 6.30e-07 | 422 | 150 | 15 | int:WWTR1 |
| Interaction | NUP35 interactions | ACAT1 SCAF8 TNRC6B PUM2 NUP42 CREBBP CIC TRIM33 KMT2C PKP3 NUP188 MAML3 EP300 PRRC2B TBX5 | 6.69e-07 | 424 | 150 | 15 | int:NUP35 |
| Interaction | GLI3 interactions | 6.98e-07 | 98 | 150 | 8 | int:GLI3 | |
| Interaction | RCOR1 interactions | APC TNRC6B PPP6R1 DCTN1 CIC HNRNPU FASN BRCA2 SYNJ1 UBR5 SMARCA4 ZBTB11 PHIP CUX1 FBXW7 TBX5 | 8.95e-07 | 494 | 150 | 16 | int:RCOR1 |
| Interaction | ERG interactions | ZNF521 CREBBP CIC HNRNPU TRIM33 KMT2C UBR5 SMARCA4 SYN1 EP300 PRRC2B | 9.22e-07 | 223 | 150 | 11 | int:ERG |
| Interaction | RICTOR interactions | YBX1 APC U2AF2 TSPYL1 DCTN1 GSN HNRNPU B4GALT1 FASN UBR5 CTDP1 KIF5B SCRIB CCDC86 PHIP EP300 CUX1 RAB5C SMAD4 FBXW7 | 9.33e-07 | 759 | 150 | 20 | int:RICTOR |
| Interaction | EGR1 interactions | 1.08e-06 | 72 | 150 | 7 | int:EGR1 | |
| Interaction | NFIX interactions | EP400 YBX1 ZNF521 SRCAP CIC KMT2C ARID2 PAX6 TAF4 CUX1 SMAD4 | 1.10e-06 | 227 | 150 | 11 | int:NFIX |
| Interaction | HNF1B interactions | 1.63e-06 | 190 | 150 | 10 | int:HNF1B | |
| Interaction | EN1 interactions | 1.69e-06 | 110 | 150 | 8 | int:EN1 | |
| Interaction | MYOD1 interactions | KAT5 EP400 UBN2 CREBBP TRIM33 KMT2C SMARCA4 EP300 CUX1 SMAD4 | 1.97e-06 | 194 | 150 | 10 | int:MYOD1 |
| Interaction | HDAC1 interactions | KAT5 EP400 RBL2 APC ZNF521 TNRC6B U2AF2 PPP6R1 DCTN1 CREBBP CIC HNRNPU PTOV1 FASN BRCA2 SYNJ1 UBR5 GLI3 SMARCA4 NKX2-5 ZBTB11 EP300 CUX1 SMAD4 | 2.27e-06 | 1108 | 150 | 24 | int:HDAC1 |
| Interaction | ELF4 interactions | 2.36e-06 | 115 | 150 | 8 | int:ELF4 | |
| Interaction | STAT2 interactions | 2.41e-06 | 81 | 150 | 7 | int:STAT2 | |
| Interaction | SOX7 interactions | 2.62e-06 | 82 | 150 | 7 | int:SOX7 | |
| Interaction | IRF4 interactions | 3.34e-06 | 85 | 150 | 7 | int:IRF4 | |
| Interaction | TOP3B interactions | TANC2 EP400 YBX1 CTC1 APBA1 TNRC6B KTI12 PPP6R1 SRCAP ZNF236 ARHGEF11 DCTN1 CIC MYORG HNRNPU TBC1D16 MST1R KMT2C FASN SYNJ1 SH3TC1 ZNF341 SLC35A2 CTDP1 ARC NUP188 EP300 PRRC2B | 3.58e-06 | 1470 | 150 | 28 | int:TOP3B |
| Interaction | CDX2 interactions | 3.61e-06 | 86 | 150 | 7 | int:CDX2 | |
| Interaction | AR interactions | KAT5 EP400 U2AF2 DIDO1 SRCAP UBN2 CREBBP CIC GSN HNRNPU TRIM33 KMT2C UBR5 GLI3 ARID2 SMARCA4 NUP188 PAX6 EP300 CUX1 PRRC2B SMAD4 | 4.35e-06 | 992 | 150 | 22 | int:AR |
| Interaction | CEBPA interactions | EVL KAT5 EP400 YBX1 DIDO1 UBN2 CREBBP CIC GSN HNRNPU SCAF4 TRIM33 KMT2C FASN UBR5 ARID2 SMARCA4 PPIL2 KIF5B TAF4 USF2 EP300 CUX1 PRRC2B SMAD4 | 5.21e-06 | 1245 | 150 | 25 | int:CEBPA |
| Interaction | EGR2 interactions | 5.50e-06 | 171 | 150 | 9 | int:EGR2 | |
| Interaction | EPAS1 interactions | 6.05e-06 | 173 | 150 | 9 | int:EPAS1 | |
| Interaction | CEBPD interactions | 6.71e-06 | 62 | 150 | 6 | int:CEBPD | |
| Interaction | GSK3B interactions | YBX1 ACR APBA1 APC TNRC6B YTHDC2 PPP6R1 LARP1B ARHGEF11 DCTN1 SYAP1 GSN HNRNPU FASN UBR5 ARC KIF5B SCRIB SMAD4 FBXW7 | 7.09e-06 | 868 | 150 | 20 | int:GSK3B |
| Interaction | APEX1 interactions | CLSTN3 EP400 YBX1 CEP85L DIDO1 SRCAP ZNF236 DCTN1 HNRNPU SLC4A2 PTOV1 USP6 BRCA2 ZFR2 ARID2 PKP3 SLC35A2 CTDP1 SMARCA4 POLR1B USF2 BAIAP3 EP300 CUX1 SMAD4 | 7.46e-06 | 1271 | 150 | 25 | int:APEX1 |
| Interaction | GSK3A interactions | YBX1 ACR APC TNRC6B U2AF2 YTHDC2 PPP6R1 LARP1B ARHGEF11 SYAP1 HNRNPU UBR5 GLI3 SCRIB | 1.00e-05 | 464 | 150 | 14 | int:GSK3A |
| Interaction | TP53BP1 interactions | EP400 CTC1 RBL2 ACR U2AF2 TSPYL1 CREBBP CIC TRIM33 FASN BRCA2 UBR5 MED25 EP300 CUX1 | 1.09e-05 | 533 | 150 | 15 | int:TP53BP1 |
| Interaction | H2BC3 interactions | KAT5 EP400 U2AF2 DIDO1 TSPYL1 SRCAP DCTN1 CREBBP KMT2C ARID2 CCDC86 EP300 CUX1 | 1.12e-05 | 406 | 150 | 13 | int:H2BC3 |
| Interaction | NR3C1 interactions | TANC2 KAT5 CSMD2 IFI35 SLC1A3 CREBBP CIC HNRNPU USP6 USP8 MAPK15 ARID2 MED25 SMARCA4 NUP188 BSN MAML3 EP300 CUX1 PRRC2B FBXW7 | 1.13e-05 | 974 | 150 | 21 | int:NR3C1 |
| Interaction | NAA40 interactions | EP400 TNRC6B PUM2 DIDO1 YTHDC2 TACC2 PPP6R1 SRCAP DCTN1 SYAP1 CIC HNRNPU SCAF4 USP8 FASN SYNJ1 ARID2 SMARCA4 KIF5B SCRIB PRRC2B | 1.20e-05 | 978 | 150 | 21 | int:NAA40 |
| Interaction | H3-3A interactions | U2AF2 DIDO1 SRCAP UBN2 CREBBP CIC KMT2C ARID2 SMARCA4 PPIL2 PAX6 TAF4 ZBTB11 BBC3 PHIP EP300 CUX1 RAB5C | 1.21e-05 | 749 | 150 | 18 | int:H3-3A |
| Interaction | KLF5 interactions | 1.59e-05 | 195 | 150 | 9 | int:KLF5 | |
| Interaction | ASF1A interactions | 1.78e-05 | 249 | 150 | 10 | int:ASF1A | |
| Interaction | PML interactions | SP2 KAT5 EP400 RBL2 TNRC6B TACC2 UBN2 CREBBP HNRNPU TRIM33 FASN UBR5 PKP3 SMARCA4 PPIL2 KIF5B TAF4 PHIP EP300 FBXW7 | 2.02e-05 | 933 | 150 | 20 | int:PML |
| Interaction | CRX interactions | KAT5 EP400 RHOXF2 UBN2 CREBBP TRIM33 KMT2C ARID2 EP300 PRRC2B | 2.12e-05 | 254 | 150 | 10 | int:CRX |
| Interaction | RBPJ interactions | 2.12e-05 | 254 | 150 | 10 | int:RBPJ | |
| Interaction | SOX4 interactions | 2.19e-05 | 76 | 150 | 6 | int:SOX4 | |
| Interaction | YTHDF2 interactions | TNRC6B PUM2 DCTN1 CREBBP CIC HNRNPU FASN GLI3 TAF4 PRRC2B FBXW7 | 2.27e-05 | 312 | 150 | 11 | int:YTHDF2 |
| Interaction | TRRAP interactions | KAT5 EP400 SCAF8 RBL2 DIDO1 SRCAP CREBBP SLC1A6 TRIM33 USP8 FASN BRCA2 UBR5 CTDP1 MED25 SMARCA4 TAF4 RAB5C | 2.45e-05 | 790 | 150 | 18 | int:TRRAP |
| Interaction | KLF4 interactions | 2.68e-05 | 160 | 150 | 8 | int:KLF4 | |
| Interaction | TBX21 interactions | 2.79e-05 | 24 | 150 | 4 | int:TBX21 | |
| Interaction | PRPF40A interactions | EVL WAS YBX1 U2AF2 HNRNPU SCAF4 MST1R SMPDL3B UBR5 ZNF341 SMARCA4 EP300 SMAD4 | 3.01e-05 | 446 | 150 | 13 | int:PRPF40A |
| Interaction | MED23 interactions | 3.14e-05 | 266 | 150 | 10 | int:MED23 | |
| Interaction | SMAD2 interactions | U2AF2 CREBBP TRIM33 KMT2C SMPDL3B BRCA2 UBR5 GLI3 MED25 SMARCA4 EP300 SMAD4 | 3.22e-05 | 385 | 150 | 12 | int:SMAD2 |
| Interaction | NKX2-5 interactions | 3.38e-05 | 82 | 150 | 6 | int:NKX2-5 | |
| Interaction | ETS1 interactions | 3.42e-05 | 121 | 150 | 7 | int:ETS1 | |
| Interaction | EP300 interactions | KAT5 YBX1 HDHD5 U2AF2 TACC2 SRCAP DUS3L CREBBP HNRNPU SCAF4 B4GALT1 FASN BRCA2 CTDP1 SMARCA4 PPIL2 KIF5B PAX6 SCRIB BSN USF2 BBC3 EP300 RAB5C SMAD4 | 3.85e-05 | 1401 | 150 | 25 | int:EP300 |
| Interaction | PBX1 interactions | 4.15e-05 | 85 | 150 | 6 | int:PBX1 | |
| Interaction | CTCF interactions | YBX1 U2AF2 CIC HNRNPU GLI3 SMARCA4 POLR1B PAX6 BBC3 EP300 RAB5C SMAD4 FBXW7 | 4.23e-05 | 461 | 150 | 13 | int:CTCF |
| Interaction | SRCAP interactions | 4.66e-05 | 127 | 150 | 7 | int:SRCAP | |
| Interaction | FMR1 interactions | YBX1 APC TNRC6B PUM2 TACC2 HNRNPU SMARCA4 KIF5B SCRIB BSN TNR CUX1 PRRC2B FBXW7 | 4.90e-05 | 536 | 150 | 14 | int:FMR1 |
| Interaction | POLR2A interactions | U2AF2 DIDO1 CREBBP CIC HNRNPU SCAF4 BRCA2 CTDP1 MED25 SMARCA4 POLR1B TAF4 EP300 FBXW7 | 4.90e-05 | 536 | 150 | 14 | int:POLR2A |
| Interaction | TEAD1 interactions | 5.29e-05 | 176 | 150 | 8 | int:TEAD1 | |
| Interaction | CDK9 interactions | CABLES2 YBX1 RBL2 APC SRCAP CREBBP GSN HNRNPU TRIM33 FASN BRCA2 UBR5 CTDP1 KIF5B EP300 SMAD4 | 5.32e-05 | 685 | 150 | 16 | int:CDK9 |
| Interaction | TCEA1 interactions | 5.68e-05 | 131 | 150 | 7 | int:TCEA1 | |
| Interaction | CTNNB1 interactions | TANC2 EP400 YBX1 APC CREBBP USP20 HNRNPU TRIM33 USP8 TSC22D1 UBR5 FBXO31 PKP3 SMARCA4 KIF5B SCRIB EP300 CUX1 SMAD4 FBXW7 | 6.08e-05 | 1009 | 150 | 20 | int:CTNNB1 |
| Interaction | HDAC6 interactions | RIPOR2 KAT5 EP400 YBX1 DCTN1 GSN HNRNPU TBC1D16 PTOV1 TRIM33 FASN BRCA2 GLI3 PKP3 POLR1B SCRIB PHIP EP300 SMAD4 | 6.24e-05 | 929 | 150 | 19 | int:HDAC6 |
| Interaction | H2BC21 interactions | EP400 DIDO1 SIK1 SRCAP CREBBP USP20 HNRNPU SCAF4 USP8 ARID2 MED25 SMARCA4 CCDC86 PHIP EP300 FBXW7 | 6.42e-05 | 696 | 150 | 16 | int:H2BC21 |
| Interaction | SOX10 interactions | 6.48e-05 | 92 | 150 | 6 | int:SOX10 | |
| Interaction | NANOG interactions | EP400 HDHD5 RHOXF2 PUM2 DIDO1 TRIM33 KMT2C BRCA2 SMARCA4 CCDC86 EP300 SMAD4 FBXW7 | 6.52e-05 | 481 | 150 | 13 | int:NANOG |
| Interaction | TERF2IP interactions | EP400 OGFR DIDO1 SRCAP CREBBP CIC PRX HNRNPU TRIM33 BRCA2 SMARCA4 PPIL2 TAF4 CUX1 | 6.71e-05 | 552 | 150 | 14 | int:TERF2IP |
| Interaction | NUP43 interactions | EP400 APC TNRC6B KTI12 NUP42 SRCAP UBN2 BRCA2 UBR5 ARID2 SMARCA4 KIF5B TAF4 ZBTB11 PHIP | 6.81e-05 | 625 | 150 | 15 | int:NUP43 |
| Interaction | SMARCC2 interactions | SRCAP CREBBP TRIM33 ZNF341 ARID2 SMARCA4 PAX6 EP300 SMAD4 FBXW7 TBX5 | 6.94e-05 | 353 | 150 | 11 | int:SMARCC2 |
| Interaction | POLDIP3 interactions | 7.29e-05 | 237 | 150 | 9 | int:POLDIP3 | |
| Interaction | SF3B3 interactions | YBX1 CTC1 WDR81 U2AF2 SRCAP DCTN1 CIC HNRNPU FASN SMARCA4 SCRIB TAF4 EP300 FBXW7 | 7.53e-05 | 558 | 150 | 14 | int:SF3B3 |
| Interaction | SRF interactions | 8.27e-05 | 139 | 150 | 7 | int:SRF | |
| Interaction | MAF interactions | 8.39e-05 | 60 | 150 | 5 | int:MAF | |
| Interaction | RNF43 interactions | APC TNRC6B U2AF2 YTHDC2 NUP42 SYAP1 UBR5 GLI3 TMEM131L NUP188 SCRIB PRRC2B | 8.69e-05 | 427 | 150 | 12 | int:RNF43 |
| Interaction | SMAD1 interactions | 8.82e-05 | 243 | 150 | 9 | int:SMAD1 | |
| Interaction | SMARCB1 interactions | APC TACC2 SRCAP CREBBP KMT2C BRCA2 UBR5 ARID2 SMARCA4 PAX6 EP300 | 9.12e-05 | 364 | 150 | 11 | int:SMARCB1 |
| Interaction | FAM120C interactions | 9.39e-05 | 191 | 150 | 8 | int:FAM120C | |
| Interaction | CDC16 interactions | 9.69e-05 | 246 | 150 | 9 | int:CDC16 | |
| Interaction | SLX4 interactions | EP400 DIDO1 TSPYL1 UBN2 CREBBP HNRNPU TRIM33 FASN BRCA2 UBR5 SMARCA4 PPIL2 NUP188 PRRC2B | 9.78e-05 | 572 | 150 | 14 | int:SLX4 |
| Interaction | CBX3 interactions | EP400 UBN2 SYAP1 CIC HNRNPU TRIM33 FASN ARID2 SMARCA4 PPIL2 TAF4 PHIP EP300 CUX1 PRRC2B | 9.84e-05 | 646 | 150 | 15 | int:CBX3 |
| Interaction | CCNA1 interactions | 1.06e-04 | 63 | 150 | 5 | int:CCNA1 | |
| Interaction | APBB1 interactions | 1.08e-04 | 195 | 150 | 8 | int:APBB1 | |
| Interaction | ECT2 interactions | NES YBX1 APBA1 TNRC6B U2AF2 VPS36 LARP1B DUS3L CEP164 GSN HNRNPU FASN PKP3 CTDP1 NUP188 SCRIB CUX1 RAB5C | 1.09e-04 | 887 | 150 | 18 | int:ECT2 |
| Interaction | MED6 interactions | 1.09e-04 | 101 | 150 | 6 | int:MED6 | |
| Interaction | NPY4R interactions | 1.09e-04 | 13 | 150 | 3 | int:NPY4R | |
| Interaction | GATA6 interactions | 1.15e-04 | 34 | 150 | 4 | int:GATA6 | |
| Interaction | PLK1 interactions | APC PPP6R1 DCTN1 CIC USP20 HNRNPU MST1R TRIM33 BRCA2 UBR5 PPIL2 FBXW7 TBX5 | 1.17e-04 | 510 | 150 | 13 | int:PLK1 |
| Interaction | FOS interactions | 1.19e-04 | 312 | 150 | 10 | int:FOS | |
| Interaction | ING1 interactions | 1.21e-04 | 103 | 150 | 6 | int:ING1 | |
| Interaction | ARIH2 interactions | KAT5 YBX1 OGFR TNRC6B U2AF2 SLC1A6 HNRNPU B4GALT1 SMARCA4 PAX6 | 1.25e-04 | 314 | 150 | 10 | int:ARIH2 |
| Interaction | KDM6B interactions | 1.28e-04 | 104 | 150 | 6 | int:KDM6B | |
| Interaction | HECTD1 interactions | YBX1 SCAF8 APC PUM2 U2AF2 DIDO1 YTHDC2 TACC2 TSPYL1 DCTN1 HNRNPU ARID2 SMARCA4 POLR1B ZBTB11 PCDH10 CCDC86 EP300 FBXW7 | 1.33e-04 | 984 | 150 | 19 | int:HECTD1 |
| Interaction | SUMO2 interactions | EP400 U2AF2 DIDO1 SRCAP CIC HNRNPU TRIM33 FASN ARID2 SMARCA4 ARC KIF5B EP300 CUX1 | 1.38e-04 | 591 | 150 | 14 | int:SUMO2 |
| Interaction | TPSAB1 interactions | 1.39e-04 | 14 | 150 | 3 | int:TPSAB1 | |
| Interaction | TFAP4 interactions | 1.51e-04 | 153 | 150 | 7 | int:TFAP4 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.19e-04 | 17 | 104 | 3 | 486 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.88e-04 | 25 | 104 | 3 | 775 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPSAB1 EVL CLSTN3 RIPOR2 WAS EP400 YBX1 CEP85L SCAF8 RBL2 TNRC6B PUM2 YTHDC2 PPP6R1 CREBBP USP20 HNRNPU TRIM33 KMT2C UBR5 ARID2 TMEM131L PLCB2 USF2 PHIP EP300 TPSB2 PRRC2B | 2.85e-08 | 1492 | 151 | 28 | M40023 |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.08e-07 | 182 | 151 | 8 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-07 | 186 | 151 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.46e-07 | 186 | 151 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.49e-06 | 164 | 151 | 7 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 1.56e-06 | 165 | 151 | 7 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 1.56e-06 | 165 | 151 | 7 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.67e-06 | 179 | 151 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.44e-06 | 186 | 151 | 7 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.69e-06 | 188 | 151 | 7 | 88b808561ebde997ac8a8bbd1d9bbda49bbb6646 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-06 | 194 | 151 | 7 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.54e-06 | 194 | 151 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-06 | 194 | 151 | 7 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-06 | 194 | 151 | 7 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.37e-06 | 199 | 151 | 7 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 5.55e-06 | 200 | 151 | 7 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.55e-06 | 200 | 151 | 7 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Sigmoid-(7)_Mast_cell-(70)_Mast|Sigmoid / shred on region, Cell_type, and subtype | 5.55e-06 | 200 | 151 | 7 | 7224ee639d56509de854203653a85ab09e6f05fe | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.55e-06 | 200 | 151 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Sigmoid-Mast_cell|Sigmoid / Region, Cell class and subclass | 5.55e-06 | 200 | 151 | 7 | 025125d8b9c6540d9cdeea7f0fe9c58aec2a16b0 | |
| ToppCell | Sigmoid-(7)_Mast_cell|Sigmoid / shred on region, Cell_type, and subtype | 5.55e-06 | 200 | 151 | 7 | bd8e0f027055bb34e99aa0e271ec3a0912f666bb | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 5.55e-06 | 200 | 151 | 7 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 5.55e-06 | 200 | 151 | 7 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | Sigmoid-Mast_cell-Mast|Sigmoid / Region, Cell class and subclass | 5.55e-06 | 200 | 151 | 7 | e7e49e192a86566ed96f1e54657dd2ebc9036d47 | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 5.55e-06 | 200 | 151 | 7 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.55e-06 | 200 | 151 | 7 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | (70)_Mast|World / shred on Cell_type and subtype | 6.11e-06 | 203 | 151 | 7 | b7af2130b4965661b5a50717a7f82d8d498f8d08 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 157 | 151 | 6 | d12f343454202da86a06d0369f8ffe5662cd091b | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.67e-05 | 158 | 151 | 6 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 159 | 151 | 6 | bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-05 | 163 | 151 | 6 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 166 | 151 | 6 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 166 | 151 | 6 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 167 | 151 | 6 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 167 | 151 | 6 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-05 | 170 | 151 | 6 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 180 | 151 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 180 | 151 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 180 | 151 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.58e-05 | 181 | 151 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 3.70e-05 | 182 | 151 | 6 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-05 | 183 | 151 | 6 | 49f3ddc1c7c04b4ca837dbd6dad995add82941d6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 3.93e-05 | 184 | 151 | 6 | 83675c7a083c52fb74dc8b9d35df0ef69715f707 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 3.93e-05 | 184 | 151 | 6 | ed266bd2d12f86e8786473e64fbcd58319cd4c2a | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 186 | 151 | 6 | f8ed078684ce6d914fd9cb1f0ef4aba36db39b3f | |
| ToppCell | facs-Heart-LA-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 186 | 151 | 6 | 1d08e60d239153c9e5ea42135d702d494d8b42b1 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.17e-05 | 186 | 151 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 187 | 151 | 6 | 0f90bce2087aecfdbb377e6f46c6e468efbb6e28 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 187 | 151 | 6 | 76c957b2976d38adb45e07bcf96c689442e1fc20 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 187 | 151 | 6 | 90a1078b0303799fba5d2ca4fa12076fd75b78b1 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 187 | 151 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 187 | 151 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 187 | 151 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.43e-05 | 188 | 151 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.43e-05 | 188 | 151 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 4.56e-05 | 189 | 151 | 6 | b46adb47768a7b6d801c457d7ba65508edfc36a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 189 | 151 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.70e-05 | 190 | 151 | 6 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.70e-05 | 190 | 151 | 6 | 7774dc0b4ae7d5920b516800f3b90cbf831f8d3d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 4.84e-05 | 191 | 151 | 6 | 781f6005673fc3504a85801a68af3e16ca84952f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-27|World / Primary Cells by Cluster | 4.98e-05 | 192 | 151 | 6 | cf989f26c0ebdc0cd12e1e41958f063e4fa3e468 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.98e-05 | 192 | 151 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 192 | 151 | 6 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.98e-05 | 192 | 151 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 192 | 151 | 6 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 5.12e-05 | 193 | 151 | 6 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.12e-05 | 193 | 151 | 6 | 47249aabdd912052aa635d276eed20d32b525393 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.12e-05 | 193 | 151 | 6 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | 3'_v3-Lung-Mast|Lung / Manually curated celltypes from each tissue | 5.27e-05 | 194 | 151 | 6 | 5e6eb81ddc9d5e22c1297734689f476d5a05bff6 | |
| ToppCell | 3'_v3-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 5.27e-05 | 194 | 151 | 6 | 7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-05 | 195 | 151 | 6 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 195 | 151 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-05 | 195 | 151 | 6 | 391d8e00dd5f988baa6dbda8414d3c020679ea2f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-05 | 196 | 151 | 6 | e08f90f7a923c2846cac859519b8dc7c0ac7cd03 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 197 | 151 | 6 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.74e-05 | 197 | 151 | 6 | 61f909737c5f630beffdd326c6844215643dbdde | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-05 | 197 | 151 | 6 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 5.91e-05 | 198 | 151 | 6 | 920d2e6603a06c2e8dcb6be127202d222c662bca | |
| ToppCell | 18-Airway|18 / Age, Tissue, Lineage and Cell class | 5.91e-05 | 198 | 151 | 6 | 3cdfcc6445858c3c54058bbd90b20b88b1771cca | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new|World / Primary Cells by Cluster | 5.91e-05 | 198 | 151 | 6 | 11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new-9|World / Primary Cells by Cluster | 5.91e-05 | 198 | 151 | 6 | c724ef958e14e17a7d8c02b9f842510c0780f635 | |
| ToppCell | 3'_v3-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 5.91e-05 | 198 | 151 | 6 | 807e3ed34739eca159dd0970f884b073e588c649 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-05 | 198 | 151 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.91e-05 | 198 | 151 | 6 | a1247a5efd92f95c6227c0e71dc8a0427eb54b7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-05 | 199 | 151 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Sepsis-URO-Myeloid-pDC|URO / Disease, condition lineage and cell class | 6.07e-05 | 199 | 151 | 6 | 1dc96a1cc313fa175fe50f0df606baa84ea5970b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-05 | 199 | 151 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-05 | 199 | 151 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.07e-05 | 199 | 151 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | (7)_Mast_cell|World / shred on Cell_type and subtype | 6.07e-05 | 199 | 151 | 6 | c0b5f1cb435da99a7e2ebac9ee7d7b1bd0e49b42 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.24e-05 | 200 | 151 | 6 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.24e-05 | 200 | 151 | 6 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.24e-05 | 200 | 151 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Transverse-(7)_Mast_cell-(70)_Mast|Transverse / shred on region, Cell_type, and subtype | 6.24e-05 | 200 | 151 | 6 | aa17354c83b0967707d995e4b74e042ac211f814 | |
| ToppCell | Transverse-Mast_cell-Mast|Transverse / Region, Cell class and subclass | 6.24e-05 | 200 | 151 | 6 | 0af942a33cc50da65129204976e24203320e206d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 6.24e-05 | 200 | 151 | 6 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 6.24e-05 | 200 | 151 | 6 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Transverse-Mast_cell|Transverse / Region, Cell class and subclass | 6.24e-05 | 200 | 151 | 6 | 5e3f5349ffbcabdca3d911fbc99a46aaa56c47c4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-05 | 200 | 151 | 6 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | severe-NK_CD56bright|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.24e-05 | 200 | 151 | 6 | 82818ab1796fdd0b8be02b341818897595eed841 | |
| Computational | Genes in the cancer module 563. | 8.21e-06 | 15 | 98 | 4 | MODULE_563 | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | COL7A1 WAS TNRC6B SRCAP IFI35 HNRNPU GLI3 SLC35A2 ARC PPIL2 EP300 | 8.04e-08 | 197 | 150 | 11 | 1545_DN |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; HL60; HG-U133A | EP400 HNRNPU PTOV1 TRIM33 CTDP1 SMARCA4 PPIL2 NUP188 RAB5C PRRC2B | 5.77e-07 | 191 | 150 | 10 | 2038_DN |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; HL60; HG-U133A | EP400 RBL2 DIDO1 HNRNPU PTOV1 TRIM33 CTDP1 SMARCA4 NUP188 PRRC2B | 6.66e-07 | 194 | 150 | 10 | 1416_DN |
| Drug | CAS 83919-23-7 | 6.83e-07 | 26 | 150 | 5 | CID000004240 | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | OGFR ARHGEF11 DCTN1 CIC GLI3 CTDP1 SMARCA4 PPIL2 USF2 PRRC2B | 7.31e-07 | 196 | 150 | 10 | 4826_DN |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.66e-07 | 197 | 150 | 10 | 2262_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 8.03e-07 | 198 | 150 | 10 | 7016_DN | |
| Drug | bis(5-amidino-2-benzimidazolyl)methane | 8.60e-07 | 12 | 150 | 4 | CID000002386 | |
| Drug | Brunfelsamidine | 1.12e-06 | 4 | 150 | 3 | CID005281683 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.15e-06 | 180 | 150 | 9 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.45e-06 | 182 | 150 | 9 | 3887_DN | |
| Drug | Azacytidine-5 [320-67-2]; Up 200; 16.4uM; PC3; HT_HG-U133A | 4.49e-06 | 188 | 150 | 9 | 4010_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 4.69e-06 | 189 | 150 | 9 | 410_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 5.56e-06 | 193 | 150 | 9 | 3262_UP | |
| Drug | NSC89634 | 5.58e-06 | 39 | 150 | 5 | CID000070877 | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.80e-06 | 194 | 150 | 9 | 3855_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A | 6.05e-06 | 195 | 150 | 9 | 1214_DN | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; PC3; HT_HG-U133A | 6.05e-06 | 195 | 150 | 9 | 6293_UP | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; HL60; HT_HG-U133A | 6.31e-06 | 196 | 150 | 9 | 3132_UP | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A | 6.31e-06 | 196 | 150 | 9 | 2827_DN | |
| Drug | C75; Up 200; 10uM; PC3; HT_HG-U133A | 6.57e-06 | 197 | 150 | 9 | 6399_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | 6.84e-06 | 198 | 150 | 9 | 6500_DN | |
| Drug | L-3-(2-naphthyl)alanine | 6.85e-06 | 70 | 150 | 6 | CID000185915 | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | 7.13e-06 | 199 | 150 | 9 | 1729_UP | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 7.13e-06 | 199 | 150 | 9 | 267_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; HL60; HG-U133A | 7.13e-06 | 199 | 150 | 9 | 1747_UP | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 7.42e-06 | 200 | 150 | 9 | 2063_DN | |
| Drug | Wkymvm | 7.44e-06 | 71 | 150 | 6 | CID000457933 | |
| Drug | ioxaglate | 9.62e-06 | 7 | 150 | 3 | CID000003742 | |
| Drug | Telebrix | 9.62e-06 | 7 | 150 | 3 | CID000034536 | |
| Drug | daphnodorin C | 2.29e-05 | 9 | 150 | 3 | CID000072428 | |
| Drug | AGEPC | TPSAB1 ENPP7 VWF KAT5 ACAT1 ACAT2 TPSD1 MAPK15 PLCB2 TPSB2 PLD4 | 2.52e-05 | 356 | 150 | 11 | CID000461545 |
| Drug | AC1Q5THZ | TPSAB1 VWF KAT5 TRH ACAT1 ACR GSN TPSD1 MAPK15 ARC PLCB2 TPSB2 PLD4 | 2.93e-05 | 502 | 150 | 13 | CID000001959 |
| Drug | AC1NUP69 | 3.25e-05 | 10 | 150 | 3 | CID005487154 | |
| Drug | 1c5s | 3.25e-05 | 10 | 150 | 3 | CID000444753 | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.61e-05 | 188 | 150 | 8 | 4835_DN | |
| Drug | sodium tetradecyl sulphate | 4.45e-05 | 11 | 150 | 3 | CID000005248 | |
| Drug | pimaradiene | 4.45e-05 | 11 | 150 | 3 | CID000440909 | |
| Drug | Z-ala-ala-lys-mna | 4.45e-05 | 11 | 150 | 3 | CID005486901 | |
| Drug | daphnodorin A | 4.45e-05 | 11 | 150 | 3 | CID000072426 | |
| Drug | AC1NSU64 | 4.45e-05 | 11 | 150 | 3 | CID005316303 | |
| Drug | methylhistamine | 4.45e-05 | 11 | 150 | 3 | CID000000912 | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; HL60; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 1840_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; HL60; HG-U133A | 4.51e-05 | 194 | 150 | 8 | 2042_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 2831_DN | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 2840_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 3695_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 3523_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | 4.85e-05 | 196 | 150 | 8 | 2044_DN | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 1323_UP | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 6447_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 4.85e-05 | 196 | 150 | 8 | 1558_DN | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 3144_UP | |
| Drug | Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 3878_DN | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; PC3; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 3996_UP | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 1686_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 1698_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 1485_DN | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 7180_UP | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 6389_UP | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; HL60; HG-U133A | 5.21e-05 | 198 | 150 | 8 | 2020_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA | 5.21e-05 | 198 | 150 | 8 | 1020_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; HL60; HG-U133A | 5.21e-05 | 198 | 150 | 8 | 1579_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 7514_DN | |
| Drug | Biotin [58-85-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 3289_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 1000uM; MCF7; HG-U133A | 5.21e-05 | 198 | 150 | 8 | 4_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 3576_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 2069_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5832_DN | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 3036_UP | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5302_DN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 4294_DN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 4390_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5879_UP | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 4633_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 3265_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 4561_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5513_DN | |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | 5.39e-05 | 199 | 150 | 8 | 578_UP | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5265_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 2287_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 7219_DN | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 2830_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 4076_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HG-U133A | 5.59e-05 | 200 | 150 | 8 | 409_DN | |
| Drug | genistein; Up 200; 10uM; PC3; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 1235_UP | |
| Drug | Glucose | WAS SCAF8 APC ZNF521 KTI12 SLC1A3 CREBBP QRICH2 TNFRSF11B GSN TSC22D1 FASN SYNJ1 ARID2 PLCB2 KIF5B PAX6 USF2 BBC3 PHIP EP300 CUX1 SMAD4 | 5.64e-05 | 1420 | 150 | 23 | ctd:D005947 |
| Drug | uPA inhibitor | 5.64e-05 | 32 | 150 | 4 | CID000001746 | |
| Drug | Elocom | 5.90e-05 | 12 | 150 | 3 | CID000123620 | |
| Drug | 4-amidinophenylpyruvic acid | 5.90e-05 | 12 | 150 | 3 | CID000151496 | |
| Drug | benzyne | 5.90e-05 | 12 | 150 | 3 | CID000123068 | |
| Drug | NSC-648146 | 5.90e-05 | 12 | 150 | 3 | CID000372649 | |
| Drug | Z-ARR-AFC | 7.64e-05 | 13 | 150 | 3 | CID000125067 | |
| Drug | Nk3201 | 7.64e-05 | 13 | 150 | 3 | CID000213050 | |
| Drug | glyphosate | 9.27e-05 | 215 | 150 | 8 | CID000003496 | |
| Drug | ABPH | 9.67e-05 | 14 | 150 | 3 | CID000092377 | |
| Drug | GPGR | 1.12e-04 | 38 | 150 | 4 | CID000485268 | |
| Drug | P-15 | 1.16e-04 | 222 | 150 | 8 | CID000200884 | |
| Drug | FdTTP | 1.20e-04 | 15 | 150 | 3 | CID000162005 | |
| Drug | NSC302991 | 1.21e-04 | 353 | 150 | 10 | CID000002538 | |
| Disease | Benign tumor of pancreas | 3.97e-07 | 13 | 146 | 4 | C0347284 | |
| Disease | Pancreatic carcinoma | 2.10e-06 | 19 | 146 | 4 | C0235974 | |
| Disease | Colorectal Carcinoma | EVL COL7A1 CLSTN3 APC PTPRT KMT2C SH3TC1 GLI3 LRP2 PHIP EP300 CUX1 RAB5C SMAD4 FBXW7 | 2.28e-06 | 702 | 146 | 15 | C0009402 |
| Disease | Squamous cell carcinoma of esophagus | 8.01e-06 | 95 | 146 | 6 | C0279626 | |
| Disease | Adenocarcinoma of large intestine | 8.51e-06 | 96 | 146 | 6 | C1319315 | |
| Disease | tryptase beta-2 measurement | 9.75e-06 | 9 | 146 | 3 | EFO_0008306 | |
| Disease | Adenoid Cystic Carcinoma | 1.08e-05 | 100 | 146 | 6 | C0010606 | |
| Disease | Intellectual Disability | TANC2 APC CIC HNRNPU KMT2C FASN SLC35A2 LRP2 PAX6 ZBTB11 PHIP | 1.49e-05 | 447 | 146 | 11 | C3714756 |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.43e-05 | 2 | 146 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.43e-05 | 2 | 146 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 2.43e-05 | 2 | 146 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.43e-05 | 2 | 146 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.43e-05 | 2 | 146 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.43e-05 | 2 | 146 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.43e-05 | 2 | 146 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.43e-05 | 2 | 146 | 2 | C0035934 | |
| Disease | Leukemia, Myelocytic, Acute | 2.58e-05 | 173 | 146 | 7 | C0023467 | |
| Disease | cancer (implicated_via_orthology) | 5.97e-05 | 268 | 146 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.01e-04 | 93 | 146 | 5 | C1535926 | |
| Disease | anorectal malformation | 1.08e-04 | 19 | 146 | 3 | MONDO_0019938 | |
| Disease | Malignant neoplasm of stomach | 1.30e-04 | 300 | 146 | 8 | C0024623 | |
| Disease | IgA glomerulonephritis (implicated_via_orthology) | 1.45e-04 | 4 | 146 | 2 | DOID:2986 (implicated_via_orthology) | |
| Disease | Sarcoma | 1.48e-04 | 21 | 146 | 3 | C1261473 | |
| Disease | Small cell carcinoma of lung | 1.50e-04 | 54 | 146 | 4 | C0149925 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 2.52e-04 | 25 | 146 | 3 | EFO_0010556 | |
| Disease | breast cancer (implicated_via_orthology) | 2.52e-04 | 25 | 146 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | EVL COL7A1 VWF YBX1 CEP85L TACC2 CIC GSN FASN BRCA2 SLC35A2 EP300 CUX1 ZNF541 FBXW7 | 2.95e-04 | 1074 | 146 | 15 | C0006142 |
| Disease | Sezary Syndrome | 3.18e-04 | 27 | 146 | 3 | C0036920 | |
| Disease | QT interval | CABLES2 CEP85L CREBBP ARID2 ALPK3 TMEM131L NKX2-5 CUX1 PRRC2B TBX5 | 3.41e-04 | 534 | 146 | 10 | EFO_0004682 |
| Disease | laryngeal carcinoma (is_marker_for) | 3.60e-04 | 6 | 146 | 2 | DOID:2600 (is_marker_for) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 3.60e-04 | 6 | 146 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.87e-04 | 69 | 146 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 5.80e-04 | 206 | 146 | 6 | C0152013 | |
| Disease | heart function measurement | 6.35e-04 | 34 | 146 | 3 | EFO_0004311 | |
| Disease | Profound Mental Retardation | 6.54e-04 | 139 | 146 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.54e-04 | 139 | 146 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.54e-04 | 139 | 146 | 5 | C0917816 | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 6.68e-04 | 8 | 146 | 2 | DOID:1312 (is_marker_for) | |
| Disease | Malignant neoplasm of urinary bladder | 6.98e-04 | 141 | 146 | 5 | C0005684 | |
| Disease | Stomach Neoplasms | 7.19e-04 | 297 | 146 | 7 | C0038356 | |
| Disease | Liver Diseases, Parasitic | 8.56e-04 | 9 | 146 | 2 | C0023897 | |
| Disease | Pancreatic carcinoma, familial | 8.56e-04 | 9 | 146 | 2 | C2931038 | |
| Disease | Glioma | 9.31e-04 | 87 | 146 | 4 | C0017638 | |
| Disease | left ventricular structural measurement | 9.72e-04 | 88 | 146 | 4 | EFO_0008205 | |
| Disease | medulloblastoma (is_implicated_in) | 1.07e-03 | 10 | 146 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Mesothelioma | 1.10e-03 | 41 | 146 | 3 | C0025500 | |
| Disease | Carcinoma, Transitional Cell | 1.10e-03 | 41 | 146 | 3 | C0007138 | |
| Disease | creatinine measurement | TRH SCAF8 OGFR TNRC6B SLC1A3 USP20 B4GALT1 LRP2 TMEM131L TAF4 BSN INS-IGF2 CUX1 | 1.38e-03 | 995 | 146 | 13 | EFO_0004518 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.45e-03 | 45 | 146 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | JT interval | 1.51e-03 | 248 | 146 | 6 | EFO_0007885 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.55e-03 | 12 | 146 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | Mitral valve prolapse, response to surgery | 1.55e-03 | 12 | 146 | 2 | EFO_0009951, HP_0001634 | |
| Disease | motor neuron disease (implicated_via_orthology) | 1.55e-03 | 12 | 146 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | Pancreatic Neoplasm | 1.56e-03 | 100 | 146 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 1.68e-03 | 102 | 146 | 4 | C0346647 | |
| Disease | Cardiomyopathy, Dilated | 1.74e-03 | 48 | 146 | 3 | C0007193 | |
| Disease | Coffin-Siris syndrome | 1.83e-03 | 13 | 146 | 2 | C0265338 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.96e-03 | 50 | 146 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.96e-03 | 50 | 146 | 3 | C1449563 | |
| Disease | Metabolic Bone Disorder | 2.13e-03 | 14 | 146 | 2 | C0005944 | |
| Disease | Sarcoma, Spindle Cell | 2.13e-03 | 14 | 146 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 2.13e-03 | 14 | 146 | 2 | C0205944 | |
| Disease | Epilepsy | 2.14e-03 | 109 | 146 | 4 | C0014544 | |
| Disease | Proteinuria | 2.45e-03 | 15 | 146 | 2 | HP_0000093 | |
| Disease | Osteopenia | 2.45e-03 | 15 | 146 | 2 | C0029453 | |
| Disease | African Burkitt's lymphoma | 2.45e-03 | 15 | 146 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 2.45e-03 | 15 | 146 | 2 | C4721444 | |
| Disease | anemia (implicated_via_orthology) | 2.45e-03 | 15 | 146 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.58e-03 | 55 | 146 | 3 | C0079744 | |
| Disease | Colorectal Neoplasms | 2.63e-03 | 277 | 146 | 6 | C0009404 | |
| Disease | Polydactyly | 2.77e-03 | 117 | 146 | 4 | C0152427 | |
| Disease | colorectal cancer (is_implicated_in) | 3.12e-03 | 121 | 146 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Benign neoplasm of stomach | 3.15e-03 | 17 | 146 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.15e-03 | 17 | 146 | 2 | C0496905 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 3.15e-03 | 17 | 146 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Carcinoma in situ of stomach | 3.15e-03 | 17 | 146 | 2 | C0154060 | |
| Disease | adverse effect, response to xenobiotic stimulus | 3.15e-03 | 59 | 146 | 3 | EFO_0009658, GO_0009410 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.46e-03 | 61 | 146 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.46e-03 | 293 | 146 | 6 | C1708349 | |
| Disease | syndrome (implicated_via_orthology) | 3.53e-03 | 18 | 146 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of endometrium | 3.53e-03 | 18 | 146 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 3.53e-03 | 18 | 146 | 2 | C0346191 | |
| Disease | Prostatic Neoplasms | 3.67e-03 | 616 | 146 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.67e-03 | 616 | 146 | 9 | C0376358 | |
| Disease | Brugada syndrome | 3.93e-03 | 19 | 146 | 2 | MONDO_0015263 | |
| Disease | bipolar disorder (is_marker_for) | 3.93e-03 | 19 | 146 | 2 | DOID:3312 (is_marker_for) | |
| Disease | cerebral infarction (is_marker_for) | 3.93e-03 | 19 | 146 | 2 | DOID:3526 (is_marker_for) | |
| Disease | carotid artery disease (is_marker_for) | 3.93e-03 | 19 | 146 | 2 | DOID:3407 (is_marker_for) | |
| Disease | urticaria | 4.36e-03 | 20 | 146 | 2 | EFO_0005531 | |
| Disease | ovarian neoplasm | 4.49e-03 | 134 | 146 | 4 | C0919267 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.51e-03 | 67 | 146 | 3 | C3463824 | |
| Disease | Schizophrenia | APC CSMD2 ARHGEF11 SLC1A3 SLC1A6 GSN LRP2 ARC SYN1 PAX6 CCDC86 | 4.57e-03 | 883 | 146 | 11 | C0036341 |
| Disease | Stomach Carcinoma | 4.80e-03 | 21 | 146 | 2 | C0699791 | |
| Disease | Malignant neoplasm of ovary | 4.86e-03 | 137 | 146 | 4 | C1140680 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGGRVAPGQRPAQGA | 431 | Q9Y5B0 | |
| PGPRQQQAGARLGAA | 46 | Q96D05 | |
| QRTGVVGQQQGLPSP | 1836 | Q09472 | |
| PQVGVPGRVAVNALA | 1706 | Q96L91 | |
| AGQSGQGKPRGQPNT | 886 | P04920 | |
| PQLVGVSTPLQGGSN | 51 | P15291 | |
| RLQQGAGLESPQGQP | 71 | Q9H6F5 | |
| FNGTQAVQVPLGGPS | 346 | Q9BQT9 | |
| NPGRLPNGIQQGSTF | 141 | Q7Z408 | |
| VQVPGRVVLQFAGPG | 1111 | Q2NKJ3 | |
| EEQQRGAIPGQAPGS | 1066 | Q14203 | |
| PQVGGGARAGQPVTL | 1131 | O94812 | |
| NPQGGVRIVGGKAAQ | 36 | P10323 | |
| GQGVLPVQGQQQGPV | 1011 | P39880 | |
| TQGPQSPRDGAQLGA | 216 | Q96PG8 | |
| GPRGGQVAKPNVILQ | 16 | Q7LC44 | |
| PGRARPGEGQQQVTT | 141 | Q96L96 | |
| GPVGVEQVQTQPRGR | 561 | Q96L96 | |
| PEELPGGTGSQQRVQ | 1126 | O15085 | |
| AGVPSPQASRVGFQN | 881 | Q68CP9 | |
| QTGVSQGQVPGAALP | 816 | Q92793 | |
| RQENCGAQQVPAGPG | 256 | Q96G46 | |
| AQGPGLGPVAAVAAQ | 261 | Q96J87 | |
| QLADGQAGRGLPVQP | 1461 | O60312 | |
| AQAQPGVPLGELGQV | 4176 | Q9HC84 | |
| PQAGSQGPQTFRQGV | 466 | Q13356 | |
| EPQNATGAPGRNRGV | 186 | P51148 | |
| QPGLVQPGADQRGLV | 421 | Q9H0J4 | |
| VQPGIVQRGLVQPGA | 626 | Q9H0J4 | |
| VQPGAVQRGLVQPGA | 636 | Q9H0J4 | |
| VQPGAVQRGLVQPGV | 646 | Q9H0J4 | |
| VQPGVDQRGLVQPGA | 656 | Q9H0J4 | |
| VQPGAVQRGLVQPGA | 666 | Q9H0J4 | |
| VQPGADQRGLVQPGV | 686 | Q9H0J4 | |
| VQPGVDQRGLVQPGV | 696 | Q9H0J4 | |
| LRAGAGQRPLTPNQG | 386 | Q8TB72 | |
| FVQNSQPVAVRGGGG | 946 | P33176 | |
| VPGQVAIQQISPGGQ | 801 | Q08999 | |
| SGVNQLGGVFVNGRP | 6 | P26367 | |
| PGARGQQEQPEGTTL | 446 | P10071 | |
| GQNLGPQAIPQDGSI | 3141 | Q8NEZ4 | |
| QAQGPRQPASGQGVG | 896 | Q96JK9 | |
| GPQVAGANENPGRNV | 116 | Q96EK9 | |
| GGGVRVASVQQVPPR | 476 | Q8TD08 | |
| LPQNLTVEGTGNPGA | 301 | Q5MY95 | |
| PGPSGAGRIVVLNTN | 181 | Q92485 | |
| PGVVNGANNPAIRVF | 311 | Q92485 | |
| PQNGAARRAVAAQPG | 171 | Q92993 | |
| AQGVAGPQLVGPTAI | 2726 | Q9UPA5 | |
| PRGLQALGQTFGANP | 316 | Q8ND23 | |
| RNTVLQGQPFGGVPT | 26 | Q9P1W3 | |
| GQGQPFVLPVGVSSR | 441 | Q5XUX0 | |
| GQFTVPLGGQQVPLR | 196 | P80217 | |
| EGGPSSQRQVQNGPS | 116 | Q9UI08 | |
| VTVAPPGARQGQQQA | 196 | Q00839 | |
| PEGQSQQVGAPGLQA | 1041 | P48681 | |
| QGVGPGLQGSPQVTL | 66 | Q6ZTU2 | |
| GPGQALQNVRAGAPG | 131 | Q6ZTU2 | |
| PAQLGAPALGGQQSV | 381 | Q71SY5 | |
| RQPIVSNPCGTNNGG | 3461 | P98164 | |
| GAGLPPQQQRTGTAL | 221 | Q9P2E7 | |
| GVGDLNAVQSPGIPQ | 296 | P52952 | |
| GRPLPQTDQVQTLGG | 3566 | Q96RW7 | |
| RGAGGGRQQPQQQPS | 26 | O15504 | |
| NVYVKVNGGPQGNPV | 121 | O14522 | |
| GPGGVNSGPVQIVNN | 241 | Q86YD1 | |
| VGLVVTQSPGAQPAG | 456 | Q96BZ4 | |
| VAPNSPSQRGGIQDG | 391 | P83110 | |
| PVGTGNQLVTFQGQP | 1496 | P51587 | |
| PGSNGKPNGQRIING | 1336 | Q4ZHG4 | |
| LVPVPGSVNGVNALG | 231 | P43003 | |
| NGEVVGVEPRPGGQN | 56 | Q969H0 | |
| QKVGGSQPPFQGQRE | 1741 | Q9BTC0 | |
| LQAPAGQQRAVGPAG | 316 | Q02410 | |
| GQQAVGGVPIQPSVR | 281 | Q5SZL2 | |
| TVPVPGSANGINALG | 256 | P48664 | |
| RVLSGGPTQQQELGP | 361 | Q02388 | |
| GPTQQQELGPGQGSV | 366 | Q02388 | |
| SRGASQAGAPQGRVP | 31 | P06396 | |
| QNGIGPLPAVNASGQ | 286 | Q9NRM1 | |
| LAPGAGAPVQSQGSQ | 16 | Q6UWV6 | |
| VVDQPLPVRGGNVGI | 376 | P49327 | |
| IGNPIPTVVSGARGN | 781 | O95104 | |
| GQPPNVTSNSGILGV | 801 | Q9UPN6 | |
| PTQVPTGLGLDGQRQ | 106 | Q9BTV7 | |
| PPALVVTANIGQAGG | 86 | F8WCM5 | |
| PVAPSQSRQGGVQGV | 541 | Q659C4 | |
| PAVALQPARGVGGQA | 31 | C0HLS1 | |
| VGGQDPGEAVQPCRQ | 431 | Q9NZT2 | |
| VRDGVAPNGSAQQLP | 41 | O14792 | |
| QSGGRLQNPLPGTVI | 751 | Q96J94 | |
| QRSPGVQPQLVLGGA | 541 | O00268 | |
| TQGQGRQSRPVAGGP | 526 | P17600 | |
| LSVPIPGGSNGDIQQ | 161 | Q9UPN9 | |
| PGGSNGDIQQVGVIR | 166 | Q9UPN9 | |
| APGQALQRVGIVGGQ | 21 | Q15661 | |
| APGQALQRVGIVGGQ | 21 | P20231 | |
| APAPGQALQQTGIVG | 26 | Q9BZJ3 | |
| GGAQGQAIEPLPNVV | 36 | A2VDJ0 | |
| NIGRSQPSPQAGLAG | 1171 | O43426 | |
| VVRQCGPQTGLQSPG | 466 | Q99593 | |
| VQRQDVAPGAGPAAQ | 41 | Q8NDG6 | |
| GAPELGAGGTRQQQP | 336 | Q9BXW7 | |
| QAAAVAGNIPGPGSV | 461 | Q13485 | |
| GADPQALGQQNRGPT | 156 | P51532 | |
| PAGQGQGQQKPLRVG | 11 | A0A0B4J2F2 | |
| PAGQGQGQQKPLRVG | 11 | P57059 | |
| QGAAVAQPNRRGAVP | 1056 | Q9HCD6 | |
| GNGPQALRQASGAPQ | 231 | Q8TE82 | |
| QGGEGQAPTRQAVLG | 96 | P24752 | |
| LQQPVAGGGQPNGDA | 11 | Q96A49 | |
| PQGAVGGLEPGNAQQ | 121 | P0C7M4 | |
| AGASVQPVGQAPAAV | 706 | Q15714 | |
| PGPRRLVGTTNQGDQ | 3191 | Q6ZRS2 | |
| QSFSPGGPNGIIRSQ | 6 | Q9Y4F9 | |
| IVQAQQAGGGGPRPL | 181 | P78381 | |
| IQSPGRNSISPGRNG | 2321 | P25054 | |
| IGVNGFTGLPPQANG | 336 | Q9BZC1 | |
| PVLGGACRQAQQPLG | 431 | Q9UPV0 | |
| VIAAPPSGGGNILQT | 616 | Q96RK0 | |
| LSGAGGPPLIQQNAS | 456 | Q9Y446 | |
| PGFGVVQAGTPERNT | 126 | O00300 | |
| GQGAVPDPTGQSVNA | 26 | Q9BYN7 | |
| QDLRVQNGGTAPPVA | 331 | O95625 | |
| VINNGNKGPPVGSRI | 776 | Q6ZU65 | |
| LPGTNQTGGPSQAVR | 96 | Q8TAM2 | |
| AQKTGVQPNGSPRGV | 301 | Q9UPR6 | |
| QTNRGPQPGRIRAVG | 141 | Q86VN1 | |
| EAANVTGPGGVPVQG | 121 | P67809 | |
| GDIQVVPIGVGPNAN | 1621 | P04275 | |
| PQSVPGVQTLLGAGR | 91 | Q8WWQ0 | |
| GQNPVRQASVGAGIP | 66 | Q9BWD1 | |
| PQDAAGRGGTPQIRV | 71 | Q9H0U9 | |
| IVQSPGGGQPAVVQQ | 286 | Q02086 | |
| GGGQPAVVQQVQVVP | 291 | Q02086 | |
| GEAGTPGQQAQSTVP | 1161 | Q9BXM0 | |
| PGTNRPGLGQNENLS | 1111 | Q96K83 | |
| QGLGVDGAQPASQPA | 166 | Q8TBP0 | |
| PTALGGLQLQQRVPG | 361 | Q92752 | |
| GGRGAPAVQQNIPST | 11 | P42768 | |
| GGQTNLRIPQGTVGQ | 506 | Q5SRE5 | |
| GAERLQGAVVPPVNG | 1756 | Q5JSZ5 | |
| QPGAAGGEIPAVQAS | 1296 | O95359 | |
| EGVVPPASGGGRVQN | 2211 | O95359 | |
| PQGAVGGLEPGNAQQ | 121 | Q9BQY4 | |
| QVGVDGAAQRPGPAA | 116 | Q15853 | |
| PSGINAQRGQLSPEG | 276 | Q00722 | |
| GGGPEIAIRQSVAQP | 881 | Q9Y2K6 | |
| QNPSQVRLPAGGGAQ | 1016 | Q8IUG5 | |
| QGSQLARGARLGQPP | 646 | Q9UPN7 | |
| SAGLQQPSGIGQRPR | 1166 | Q9H6S0 | |
| LTGVPGGRAQPEAAQ | 16 | P20396 | |
| GGLTQAPGNPVLAVQ | 176 | P26368 | |
| QVAGVSGNLAPGNQP | 1636 | Q9UL36 | |
| VTNQPIGGRNVQGGI | 1021 | Q9H9Y6 | |
| SVPLSLQVGGAQVPG | 746 | Q04912 | |
| AANSPQVVLGPSRGG | 151 | Q9BZD7 | |
| QIRNLNPVFGGSGPA | 761 | P40818 | |
| PVGTQGVPSLALAQG | 426 | P35125 | |
| IVSQEEQGGQPGQPT | 326 | Q562E7 | |
| GGNNAKRVAVPNGQP | 66 | Q9UPQ9 | |
| GGGQVELIPNGVNIP | 2611 | O95071 | |
| TGQRQTQLGGEEPPG | 696 | Q9H0D2 | |
| VGQVARPGPTAVGNG | 241 | Q96CT2 | |
| GAPGQGTQQPARTLF | 106 | Q9NR64 | |
| GNAVPQRTAGGDVPE | 556 | Q6NSJ0 |